Introduction {#s1}
============

Maps of synaptic connectivity establish robust neuronal networks defining circuit function and behavior. Modified local or global connectivity is observed in numerous neurodevelopmental disorders, including schizophrenia and autism ([@bib7]; [@bib20]; [@bib39]). Furthermore, genes that govern wiring processes are commonly associated with such diseases ([@bib27]). However, establishment of the proper connectivity is not a trivial process: There appears to be no correlation between how widely two neurons contact each other and how often they would participate in a synapse ([@bib19]), and the large numbers of neuronal cell types in dense neuropils present a significant challenge for how a genetically encoded program can establish the specific connectivity patterns.

In stereotyped neuronal networks, synaptic connectivity is believed to be dictated by cell surface proteins and secreted molecules, which can (1) assign unique identities to neurons, and (2) mediate axon guidance and synaptic targeting functions through specific interactions with their cognate ligands and receptors. This paradigm of *chemoaffinity*, first elaborated by Roger Sperry, has been supported by the discovery of a number of molecules that participate in wiring-related functions, especially in axon guidance ([@bib34]). Many of these chemoaffinity molecules function as neuronal adhesion molecules, and are conserved across animal taxa from nematodes to mammals. Nevertheless, discovery of synapse-targeting adhesion molecules, proteins that determine which pairs of neurons will create synapses, has been limited.

We have recently identified interactions between two groups of *Drosophila* IgSF (immunoglobulin superfamily) cell adhesion molecules with properties closely matching a neuronal chemoaffinity function: 21 Dpr proteins, named after the founding member Defective proboscis extension response ([@bib29]), selectively bind nine proteins, now called the Dpr-interacting proteins, or DIPs ([@bib32]). Dprs and DIPs are expressed across the nervous system. In agreement with the paradigm that they can serve as 'identity tags' on neurons, different combinations of Dprs and DIPs are known to be expressed on different neuronal classes in the optic lobe, giving neuronal surfaces unique 'identity codes' ([@bib8]; [@bib40]). A similar expression pattern has been observed in the ventral nerve cord ([@bib32]) and the olfactory system ([@bib6]). Most importantly, in the knockouts of the interacting pair Dpr11 and DIP-γ, synapse targeting defects have been observed in the optic lobe for synapses formed between Dpr11 and DIP-γ-expressing neurons ([@bib8]). Therefore, Dprs and DIPs are strong candidates for a synapse specification or targeting function. In addition, they have been shown to be necessary for neuronal survival in the optic lobe, and synapse maturation of neuromuscular junctions ([@bib8]), both important aspects of establishing functional neural circuits.

To mediate a wiring specificity function, Dprs and DIPs cannot promiscuously interact with all possible binding partners. Accordingly, out of 189 possible Dpr--DIP interaction pairs, only 36 Dpr--DIP interactions could be demonstrated ([@bib8]). The mechanisms by which molecular recognition, and therefore cellular connectivity, is established between cognate Dpr--DIP pairs is not clear: Our crystal structure of the first Dpr--DIP complex, Dpr6 bound to DIP-α, showed a role for shape complementarity, but no clear determinants of specificity were identified ([@bib8]). Comparative structural studies are necessary for revealing how similar sets of Dpr and DIP molecular interfaces can be used to create a multitude of productive protein complexes, while excluding others.

In this study, we undertook a structural, biophysical and biological characterization of Dpr and DIP adhesive complexes to explain the molecular basis of Dpr--DIP specificity and function. We present several crystal structures, including the complexes of three Dprs for which a neural phenotype has been demonstrated: Dpr11 with DIP-γ, Dpr1 with DIP-η and Dpr10 with DIP-α. We compare the interaction interfaces of heterophilic and homophilic complexes with respect to differences that lead to specificity as well as interaction energetics. Furthermore, we investigate structure-based rational design and strategies for switching affinities between Dprs and DIPs. Specifically, we demonstrate that structure-based mutagenesis of selected Dpr--DIP pairs can be used to study specific wiring defects and are useful tools for understanding circuit wiring in the *Drosophila* nervous system. With these tools, we establish that homo- and heterodimeric interactions of DIP-α are both required for proper wiring between a motor neuron and a postsynaptic muscle target. Overall, the work presented here provides a biochemical and structural framework for investigating protein families that may function as molecular specificity molecules in synaptic partner matching.

Results {#s2}
=======

Sequence relationships of Dpr and DIP subclasses explain the Dpr--DIP interactome {#s2-1}
---------------------------------------------------------------------------------

All 21 Dprs and nine DIPs are predicted to contain two and three immunoglobulin (IG) domains, respectively ([Figure 1a](#fig1){ref-type="fig"}). Dpr and DIP sequences can be easily identified across all major arthropod groups; however, there is little to no sequence conservation outside the predicted immunoglobulin domains. Despite the lack of conservation, most Dprs and DIPs contain signal sequences at their N termini, and hydrophobic patches, likely to be transmembrane helices or GPI linkage sites, at or close to their C termini. Therefore, we predict Dprs and DIPs to be cell surface glycoproteins. Our previous work identified the first IG domains, termed IG1, as the domains mediating the Dpr--DIP interaction by the formation of a pseudo-symmetric IG1-IG1 heterocomplex using the *GFCC'C'* face of the immunoglobulin fold ([@bib8]).

![Dprs and DIPs can be classified into five classes based on sequence relationships and their interactions.\
(**a**) Cellular topologies and domain compositions of Dprs and DIPs. (**b**) Phylogenetic tree of Dprs and DIPs based on sequence alignments covering all IG domains. The colored lines indicate observed interactions mediated by IG1s. The scale bar represents 0.5 substitutions per site.](elife-41028-fig1){#fig1}

Dpr and DIP sequences covering the IG domains can be aligned within each of the families to create phylogenetic trees, which demonstrate that closely related Dprs interact with the same DIPs, and closely related DIPs interact with the same set of Dprs ([@bib32]) and [Figure 1b](#fig1){ref-type="fig"}): The average sequence identities in IG1 domains for Dprs and DIPs are 44 ± 9% and 53 ± 10%, respectively (±indicates standard deviation). The closely related DIPs-η and -θ, 71% identical in their IG1 domains, commonly interact with Dprs 1, 2 and 3, which are 65% identical in IG1. Based on phylogeny, Dprs and DIPs can both be classified into five subclasses, and each Dpr subclass can be assigned to a DIP subclass as cognates. 31 out of 36 interactions reported in [@bib8] are between the cognate Dpr and DIP subclasses. Therefore, the evolutionary histories of the Dprs and DIPs greatly explain the Dpr--DIP interaction network; however, a molecular and structural basis for specificity of Dpr--DIP interactions has remained elusive.

Shared and divergent features in the structures of Dpr--DIP heterocomplexes {#s2-2}
---------------------------------------------------------------------------

Our first structure, Dpr6 IG1 bound to DIP-α IG1 +2, showed highly complementary interaction surfaces (shape complementary value, *sc* = 0.74), but included one hydrogen bond pair, two marginal hydrogen bonds (at 3.5 Å donor-to-acceptor distance) and no salt bridges between Dpr and DIP side chains, leaving shape complementarity as the major strategy for explaining Dpr6--DIP-α specificity ([@bib32]). Since there is significant sequence diversity for residues at the Dpr--DIP interface, it was not clear if this explanation would hold for the 35 remaining Dpr--DIP pairs.

For a comparative analysis of Dpr--DIP complexes, we set out to determine structures of complexes of Dprs and DIPs from branches distant to Dpr6 and DIP-α. We chose complexes of Dpr1 and Dpr11, as they are reported to have neuronal phenotypes ([@bib8]; [@bib29]), and therefore these complex structures can be directly used to investigate the relationship between Dpr--DIP interactions and the observed phenotypes. We crystallized and solved the structures of Dpr1 IG1 with DIP-η IG1, and Dpr11 IG1 with DIP-γ IG1 +2 ([Table 1](#table1){ref-type="table"}). Overall, the three IG1-IG1 heterodimers, including the Dpr6--DIP-α pair, can be confidently overlaid: the average root-mean-square deviation (RMSD) of all IG1 Cα atoms within the three complex structures is 0.78 Å (±0.14). All three complex interfaces are comprised of the same set of residues belonging to the *GFCC'C'* face of the IG domains ([Figure 2](#fig2){ref-type="fig"}). Interestingly, while the pairwise sequence identities among the three Dpr--DIP pairs are comparable (49% to 56%), the Dpr11--DIP-γ structure is significantly different than the other two. When the interface residues at the Dpr subunits are superimposed, the three DIP subunits are slightly displaced, with DIP-γ (dark gray in [Figure 3](#fig3){ref-type="fig"}) more distant from the other DIPs (\~1.2 Å at the interface and up to 3 Å at the back face of the IG domain, [Figure 3a](#fig3){ref-type="fig"}; see [Figure 3---figure supplement 1b](#fig3s1){ref-type="fig"} for details of the displacement at the interface). Hence, different Dpr--DIP complexes can be established not only through shape complementarity between Dpr and DIP surfaces, but also by small but significant movements of the Dpr and DIP monomers with respect to each other, a mechanism not commonly recognized for related interaction pairs.

![Structural comparison of three heterodimeric Dpr--DIP complexes.\
(**a**) Dpr1--DIP-η, Dpr6--DIP-α, and Dpr11--DIP-γ structures overlaid by aligning Dpr IG1 domains. (**b**) Side-by-side comparison of the structures.](elife-41028-fig2){#fig2}

![Conserved and variable features of interaction surfaces in the heterodimeric Dpr--DIP complexes.\
(**a**) Three heterophilic complexes overlaid by aligning the *GFCC'C'* sheets of the Dpr subunits. Displacement of the DIP subunits is illustrated with arrows. (Also see [Figure 3---figure supplement 1b](#fig3s1){ref-type="fig"}.) (**b**) Sequence alignment of parts of the IG1 domains from Dprs 1, 6, 11 and DIPs-η, α, and γ. Amino acids within 4 Å of the heterophilic partner, that is at van der Waals or hydrogen bonding distances at the Dpr--DIP interface, are labeled in red boxes. \* indicates core interface positions in Dprs and DIPs. (**c**) The conserved hydrophobic core at the interface. The coloring scheme in [Figure 2](#fig2){ref-type="fig"} is used to distinguish Dprs and DIPs. Lighter colors present Dprs. Labels for DIP residues are underlined. Labels in light pink and magenta are for Dpr1 and DIP-η, respectively. Schematics in c~1~ to c~3~ show the conserved knob-and-hole interactions at the hydrophobic core. (**d**) The hydrophilic periphery of the interface. Labels for DIP residues are underlined. d~1~ and d~2~ show highly variable positions at the Dpr--DIP interface. For additional structural images, see [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.](elife-41028-fig3){#fig3}
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###### Data and refinement statistics for x-ray crystallography of Dpr--DIP-η and Dpr11--DIP-γ complexes, and DIP-γ alone.

  ---------------------------------------------------------------------------------------------------------------
                                      Dpr1 IG1 +\                 Dpr11 IG1 +\            DIP-γ IG1-IG2
                                      DIP-η IG1                   DIP-γ IG1-IG2           
  ----------------------------------- --------------------------- ----------------------- -----------------------
  Space Group                         *P*4~3~2~1~2                *P*4~3~2~1~2            *P*2~1~

  *Cell Dimensions*                                                                       

  *a*, *b*, *c* (Å)                   74.08, 74.08, 235.45        85.36, 85.36, 103.58    29.33, 43.44, 86.14

  *α*, *β*, *γ* (°)                   90, 90, 90                  90, 90, 90              90, 90.46, 90

  Resolution (Å)                      50--2.40 (2.44--2.40)^\*^   50--2.50 (2.65--2.50)   50--1.85 (1.90--1.85)

  *R*~sym~ (%)                        14.0 (66.4)                 16.1 (181.8)            14.6 (71.6)

  *\<I* \> /\<*σ*(*I*)\>              22 (1.8)                    16.5 (1.2)              8.8 (1.6)

  *CC*~1/2~                           (77.0)^†^                   99.8 (57.7)             99.6 (82.8)

  Completeness (%)                    93.4 (55.7)                 99.7 (98.1)             99.9 (99.8)

  Redundancy                          13.6 (4.7)                  13.3 (8.6)              6.4 (3.8)

  **Refinement**                                                                          

  Resolution (Å)                      50--2.40 (2.49--2.40)^\*^   50--2.50 (2.69--2.50)   50--1.85 (1.95--1.85)

  Reflections                         25,031                      13,767                  18,695

  *R*~cryst~ (%)                      21.22 (31.41)               20.88 (29.94)           20.45 (25.71)

  *R*~free~ (%)‡                      24.44 (34.15)               26.29 (35.07)           23.46 (30.55)

  *Number of atoms*                                                                       

  Protein                             3403                        2312                    1622

  Ligand/Glycans                      192                         81                      38

  Water                               84                          69                      179

  *Average B-factors (Å^2^)*                                                              

  All                                 55.1                        56.4                    32.8

  Protein                             53.7                        55.7                    31.5

  Ligand/Glycans                      84.3                        83.4                    60.0

  Solvent                             46.3                        47.3                    38.6

  *R.m.s. deviations from ideality*                                                       

  Bond Lengths (Å)                    0.004                       0.005                   0.008

  Bond Angles (°)                     0.995                       0.741                   0.956

  *Ramachandran statistics*                                                               

  Favored (%)                         95.91                       96.88                   98.53

  Outliers (%)                        0.0                         0.0                     0.0

  Rotamer Outliers (%)                0.0                         0.0                     0.0

  All-atom Clashscore ^§^             5.48                        5.64                    6.60

  Coordinate Error *^¶^* (Å)          0.30                        0.41                    0.21
  ---------------------------------------------------------------------------------------------------------------

^\*^The values in parentheses are for reflections in the highest resolution bin.

^†^Data processed by *HKL2000*, which does not report *CC*~1/2~ for the entire resolution range of the data.

^‡^5% of reflections was not used during refinement for cross-validation: 1247, 707 and 933 reflections for the Dpr1--DIP-η, Dpr11--DIP-γ, and DIP-γ-only structures, respectively.

^§^As reported by *Molprobity*.

*^¶^* Maximum-likelihood estimate for coordinate error, reported by *phenix.refine*.

During our crystallization trials, we also grew crystals and determined the structure of DIP-γ IG1 +2 in a monomeric state. This has allowed us to compare three structures containing DIP IG1 and IG2 domains and the relative orientations of these IG domains ([Figure 2a](#fig2){ref-type="fig"}). In all structures, the two IG domains are in an extended conformation. This is unlike many multi-IG domain cell adhesion molecules known to adapt horseshoe-like structures, which require minimally four-amino acid linkers for the U turn ([@bib13]; [@bib35]; [@bib38]), but is similar to cadherins ([@bib36]) and certain classes of immunoglobulin superfamily receptors, such as the Synaptogenesis (SYG) proteins ([@bib33]). The extended conformation is due to lack of linker sequences between the two IG domains in DIPs, which also holds true at the predicted DIP IG2-IG3 and the Dpr IG1-IG2 boundaries. However, despite the lack of sizeable linker sequences, the DIP IG1-IG2 domain boundary is flexible, allowing for movement of the DIP IG2 with respect to IG1. This is a result of the lack of stabilizing influences such as calcium ions found in cadherin domain boundaries ([@bib36]) or hydrogen bonds between the domains observed in SYG-1 and SYG-2 ([@bib33]). In the cases of cadherins and SYGs, rigidity of ectodomains was shown to be necessary for function and signaling. Lack of rigidity in Dprs and DIPs might indicate that they may not serve as signaling receptors directly and may not relay force or connect to cytoskeleton. This is corroborated by the fact that most Dprs and DIPs do not appear to have intracellular regions, supporting a model where Dprs and DIPs function as adhesion and specificity receptors on neuronal surfaces, but rely on co-receptors to relay signal intracellularly.

Molecular details of Dpr--DIP complex interfaces driving specificity {#s2-3}
--------------------------------------------------------------------

We next compared the Dpr--DIP interaction surfaces of the three heterocomplexes of Dpr1, 6 and 11, which belong to different subclasses and should therefore present largest differences among heterocomplexes ([Figure 3b--d](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). The centers of the interfaces are highly hydrophobic and conserved in sequence (marked in [Figure 3b](#fig3){ref-type="fig"} with \*, [Figure 3c](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} (yellow side chains)), and likely provide significant energetic contributions to binding while not contributing to Dpr--DIP specificity. Yet, we also observed differences at these conserved positions at the structural level via rotameric changes and by rigid-body movements of DIPs with respect to Dprs ([Figure 3c](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1c,d](#fig3s1){ref-type="fig"}), which allow for multiple complexes between Dprs and DIPs to form utilizing the same positions as conserved contact sites.

Outside the hydrophobic core, the interface residues are more polar, and significant differences in sequence and structure are present ([Figure 3d](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1a](#fig3s1){ref-type="fig"} (cyan side chains)). To visualize how specificity is established, we focused on residue positions with stark differences among the three Dprs and DIPs in the periphery of the interface. Surprisingly, these sequence differences and their structural consequences, in several cases, cannot be explained by simple substitution of electrostatic or hydrophobic interactions. For example, Val164 in Dpr6 is a lysine in Dpr1 and Dpr11 ([Figure 3d~1~](#fig3){ref-type="fig"}). However, this Val to Lys substitution is not accompanied by the presence of hydrophobic and acidic residues in DIPs directly interacting with this position. Instead, the presence of two Cγ atoms in Val164 results in crowding and an Ala82 in DIP-α, which is otherwise a valine in Dpr1 and Dpr11. Remarkably, the lysine residues replacing Val164 in Dpr1 and 11 do not form any salt bridges or hydrogen bonds to side chains in DIP-η and -γ, but serve in van der Waals interactions with DIPs.

A second highly variable position, Leu154 in Dpr11 (Lys in Dpr1 and His in Dpr6) also fails to explain specificity via simple electrostatic or hydrophobic matching ([Figure 3d~2~](#fig3){ref-type="fig"}): The interfacing residue in the three DIPs is a glutamine or lysine (Gln78 of DIP-γ), which is pushed away by the hydrophobic Leu154 of Dpr1, but not in complexes with Dpr6 or 11. This movement of Gln78 in DIP-γ is then accommodated by a glycine in Dpr11 position 157, which is otherwise a bulkier and hydrophobic Leu and Ile in Dpr1 and 6. Therefore, the Dpr11--DIP-γ crystal structure enables us to see that Leu154 and Gly157 in Dpr11 are structurally linked and are needed for DIP-γ binding. Interestingly, the position equivalent to Gly157 of Dpr11 (and Dpr15) in the two other DIP-γ binders, Dprs 16 and 17, are larger but *polar* amino acids ([Figure 3d~2~](#fig3){ref-type="fig"}), which can still be accommodated at the site as hydrogen bond participants with Q78 in DIP-γ.

We further looked to understand specificity via co-variation of Dpr and DIP residues in interacting pairs. We hypothesized that if there are sites in Dprs and DIPs that co-evolve, these could correspond to specificity determinants. For an analysis of sequence co-variation, we created artificial sequences where each sequence contained the IG1 from a Dpr, followed by the IG1 from a cognate DIP, resulting in 36 sequences. Covariation analysis by available tools is hindered due to the requirement for larger numbers of sequences. However, one method, the statistical coupling analysis (SCA) version 5 ([@bib24]), identified one pair of amino acids, Dpr His94 (Dpr1) and DIP Met132 (DIP-η) ([Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}). These two residues directly contact each other and cap the hydrophobic interior of the interface ([Figure 1---figure supplement 1b](#fig1s1){ref-type="fig"}). In DIP-ε and -ζ, the methionine is replaced by an alanine, and ε-/ζ- binders Dprs 14, 18, 19 and 20 have non-histidine amino acids in the statistically coupled Dpr position ([Figure 1---figure supplement 1c](#fig1s1){ref-type="fig"}). It would be of future interest to determine the structures of DIP-ε and -ζ complexes to reveal the nature of the interaction at these positions. Overall, it appears that Dpr--DIP specificity is encoded not only by relationships between pairs of Dpr and DIP residues (e.g., K144 in Dpr1 with T83 in DIP-η, [Figure 3d~1~](#fig3){ref-type="fig"}), but also through coupling of multiple residues, and through shape complementarity, where rotameric changes help create complementary surfaces.

Energetics of the Dpr--DIP complex interface {#s2-4}
--------------------------------------------

While we could demonstrate and explain structural and amino acid differences between the three Dpr--DIP complexes through crystallography, static structures can rarely elucidate energetics of binding. To compare the three complexes from a thermodynamic point-of-view, we analyzed the same set of residues previously mutated in the Dpr6-DIP-α complex ([@bib8]) in Dpr1--DIP-η and Dpr11--DIP-γ complexes via alanine mutagenesis, followed by heterophilic affinity measurements using surface plasmon resonance (SPR) (see [Figure 4a--d](#fig4){ref-type="fig"} for binding isotherms, and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} to 3 for raw SPR data). The amino acids at the four positions in the three Dpr--DIP complexes (total of 24 positions) are shown in [Figure 4e](#fig4){ref-type="fig"}, and the effect of alanine mutagenesis, converted to ΔΔ*G* values and fold-loss of binding, are in [Figure 4f](#fig4){ref-type="fig"} and [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}.

![Energetics and engineering of Dpr--DIP interfaces.\
(**a--d**) Corresponding sets of Dpr and DIP interface residues are mutated in Dpr1 (**a**), DIP-η (**b**), Dpr11 (**c**) and [@bib8]), DIP-γ (**d**) and [@bib8]), Dpr6 and DIP-α ([@bib8]). Binding isotherms for wild-type and mutants tested in this study are plotted with fits to a 1:1 interaction model. (**e**) The amino acids at the four mutated sites in six Dpr and DIP heterophilic partners. (**f**) Effects of alanine mutagenesis at the four sites in energy terms (from [Figure 4---figure supplement 2a](#fig4s2){ref-type="fig"}). (**g**) Comparison of Dpr6 and Dpr11 IG1 sequences. **\*** highlights variable amino acids at the interface. (**h,i**) Binding of Dpr11 mutants to the native partner DIP-γ and the engineering target DIP-α using ECIA in two cycles. (**j**) Comparison of the interactions of conversion mutation sites (A165Y and F167Y) between the Dpr6--DIP-α and Dpr11--DIP-γ complexes.](elife-41028-fig4){#fig4}

With these data, we first investigated the His94 (Dpr1) to Glu126 (DIP-η) hydrogen bond ([Figure 3d](#fig3){ref-type="fig"}), which appeared to be the only conserved side chain-to-side chain hydrogen bond among the three heterophilic complexes based on sequence conservation. For the Dpr1--DIP-η and Dpr6--DIP-α complexes, His-to-Ala mutation unexpectedly *increased* affinity despite removing a hydrogen bond and significant packing ([Figure 4a--f](#fig4){ref-type="fig"}). However, in Dpr11--DIP-γ, for which our structure unexpectedly shows no hydrogen bond, the His-to-Ala mutation abolished binding by more than five-fold. On the DIP side, the Gln-to-Ala mutation universally decreased or abolished affinity. These results indicate that even relatively conserved side chain-to-side chain hydrogen bonds can be dispensable for binding, and our ability to predict binding energetics based on static structures is limited. Interestingly, the His94 (Dpr1) residue is one of the statistically coupled residues mentioned above.

For hydrophobic side chains at the core of the interface, single-site alanine mutations consistently resulted in loss of affinity, and sometimes almost completely abolished binding ([Figure 4a--f](#fig4){ref-type="fig"}). We were not able to observe a rank order, or if a certain position is energetically more important across multiple complexes, that is a conserved hotspot. ([Figure 4---figure supplement 2a--b](#fig4s2){ref-type="fig"}). Therefore, we conclude that while the energetics of the interface shows some variation among the complexes, the hydrophobic conserved core of the interface provides much of the energy of binding, and the periphery is likely responsible for specificity.

Structure-based alteration of dpr/DIP specificities {#s2-5}
---------------------------------------------------

Engineered variants of Dprs and DIPs can be used to study wiring specificity in the *Drosophila* nervous system. In addition to the mutations described above, which decreased or increased affinities compared to wild-type, mutants with modified specificities can prove especially useful. For this purpose, we took a rational approach to modify Dpr11 to bind DIP-α. As DIP-α binds Dpr6, we substituted every interface amino acid in Dpr11 to its equivalent in Dpr6 (marked by \* in [Figure 4g](#fig4){ref-type="fig"}), and performed a highly sensitive, high-throughput ELISA-like binding assay, the extracellular interactome assay (ECIA) ([@bib32]). This method can be used to report interactions with affinities as weak as approximately 1 mM ([@bib32]), and was used to originally discover Dpr--DIP interactions.

The first round of single-site and some double-site mutagenesis identified Dpr11 A165Y and two double mutants to weakly interact with DIP-α (marked by **+**, [Figure 4h](#fig4){ref-type="fig"}). Further installation of Dpr6 amino acids at the DIP-binding interface of Dpr11 slightly improved DIP-α affinity ([Figure 4i](#fig4){ref-type="fig"}). As a result of the second round of mutagenesis, we identified a triple-mutant Dpr11 variant, A165Y F167Y K207V (marked by **\***), which binds DIP-α and -γ. Interestingly, further non-exhaustive mutagenesis of the Dpr11 interface beyond A165Y F167Y K207V resulted in loss of binding to both DIPs. The identification of these residues is not accidental: two of the mutations are non-conservative changes in the polar periphery of the interface ([Figure 4---figure supplement 2c](#fig4s2){ref-type="fig"}); the K207 position was already highlighted as a specificity determinant above, and in [Figure 3d~1~](#fig3){ref-type="fig"}. The A165Y mutation is expected to create of a hydrogen bond absent in the Dpr11--DIP-γ complex but present in Dpr6--DIP-α and the engineered Dpr11 A165Y F167Y K207V--DIP-α complex ([Figure 4j](#fig4){ref-type="fig"}). Overall, this set of experiments demonstrates that Dpr/DIP specificities can be modified through rational design and the use of an inexpensive, high-throughput, fast and sensitive interaction assay.

DIP homodimers are structurally similar to Dpr--DIP heterodimers {#s2-6}
----------------------------------------------------------------

As we purified and crystallized several Dpr--DIP complexes, we were also able to grow crystals of DIP-η IG1 and determined its structure at 1.9 Å resolution, which revealed a homodimer ([Table 2](#table2){ref-type="table"}). These crystals only grew in the absence of Dpr1, which indicated that the heterodimers are likely more stable than the homodimer under the crystallization conditions used. The homodimeric DIP-η structure closely mimicked the Dpr1--DIP-η heterodimer: When DIP-η monomers were aligned, the other subunits, DIP-η in the homodimer and Dpr1 in the heterodimer, were only displaced by an RMSD of 0.78 Å for 87 out of 102 Cα atoms, excluding the variable DE loop and the mobile half of the A strand ([Figure 5a](#fig5){ref-type="fig"}). This is comparable to differences observed between heterophilic complexes. The main chain positions of a DIP-η bound to either another DIP-η or Dpr1 are virtually identical, and surprisingly, most side chains also preserve their rotameric states ([Figure 5b](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1b](#fig5s1){ref-type="fig"}). On the other side of the interface, sequence differences between Dpr1 and DIP-η appear to not cause large deviations in the main chain atom positions between the two complexes ([Figure 5c](#fig5){ref-type="fig"}).

![Structural comparison of DIP-η homodimer complex with the Dpr1--DIP-η heterocomplex.\
(**a**) Side-by-side aligned views of the hetero- and homophilic complexes of DIP-η. (**b--c**) The *GFCC'C'* faces involved in the heterophilic (magenta and pink) and homophilic (dark green and green) complexes. (**d**) DIP-η can accommodate binding both DIP-η and Dpr1 by rearranging the rotameric states of its interface residues. (**e**) Gel filtration chromatography of DIP-η IG1 at six concentrations. DIP-η is in a fast-exchange dimer-to-monomer equilibrium in the mid-micromolar range. The chromatograms are drawn at different scales shown at both sides of the plot. Path length of the UV flow cell is 0.2 cm. Elution volumes for gel filtration standards are labeled with filled triangles above the chromatograms. DIP-η peak elution positions are plotted against concentration in [Figure 5---figure supplement 1c](#fig5s1){ref-type="fig"}.](elife-41028-fig5){#fig5}
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###### Data and refinement statistics for x-ray crystallography of DIP-η--DIP-η and Dpr10--DIP-α complexes.

  ---------------------------------------------------------------------------------------
                                      DIP-η IG1 +\                Dpr10 IG1 +\
                                      DIP-η IG1                   DIP-α IG1
  ----------------------------------- --------------------------- -----------------------
  Space Group                         *C*2                        *P*1

  *Cell Dimensions*                                               

  *a*, *b*, *c* (Å)                   88.43, 67.13, 61.01         51.01, 53.55, 56.69

  *α*, *β*, *γ* (°)                   90, 128.82, 90              119.68, 103.77, 92.88

  Resolution (Å)                      50--1.90 (1.94--1.90)^\*^   50--1.80 (1.91--1.80)

  *R*~sym~ (%)                        4.1 (55.9)                  3.3 (51.5)

  *\<I* \> /\<*σ*(*I*)\>              12.3 (2.0)                  11.8 (1.3)

  *CC*~1/2~                           99.8 (90.1)                 99.9 (67.0)

  Completeness (%)                    98.3 (93.3)                 86.8 (53.8)

  Redundancy                          3.4 (3.3)                   1.8 (1.7)

  **Refinement**                                                  

  Resolution (Å)                      50--1.90 (1.98--1.90)^\*^   50--1.80 (1.84--1.80)

  Reflections                         21,783                      40,105

  *R*~cryst~ (%)                      23.21 (37.57)               17.43 (39.51)

  *R*~free~ (%)†                      26.93 (45.88)               20.54 (53.17)

  *Number of atoms*                                               

  Protein                             1690                        3421

  Ligand/Glycans                      40                          282

  Water                               21                          296

  *Average B-factors (Å^2^)*                                      

  All                                 68.2                        42.8

  Protein                             67.9                        41.2

  Ligand/Glycans                      86.4                        58.5

  Solvent                             55.2                        46.1

  *R.m.s. deviations from ideality*                               

  Bond Lengths (Å)                    0.003                       0.008

  Bond Angles (°)                     0.636                       0.938

  *Ramachandran statistics*                                       

  Favored (%)                         97.60                       97.85

  Outliers (%)                        0.0                         0.0

  Rotamer Outliers (%)                1.04                        0.53

  All-atom Clashscore ^‡^             1.44                        3.59

  Coordinate Error ^§^ (Å)            0.16                        0.23
  ---------------------------------------------------------------------------------------

^\*^The values in parentheses are for reflections in the highest resolution bin.

^†^5% of reflections was not used during refinement for cross validation: 1247 and 2002 reflections for the DIP-η--DIP-η and Dpr10--DIP-α structures, respectively.

^‡^As reported by *Molprobity*.

^§^Maximum-likelihood estimate for coordinate error, reported by *phenix.refine*.

The crystal structures also reveal how DIP-η can accommodate binding to both Dpr1 and itself, with significant differences in sequence at the interface ([Figure 5---figure supplement 1a](#fig5s1){ref-type="fig"} and [Figure 5d](#fig5){ref-type="fig"}). For example, Tyr103 in Dpr1 (Y, F, or H in Dprs) is replaced by Ile92 in DIP-η (I or V in DIPs). This results in rotameric differences in close-by residue Ile87 in the common DIP-η subunit, which is further accommodated by other rotameric changes in the common DIP-η subunit, and sequence differences between the heterophilic and homophilic partners ([Figure 5d](#fig5){ref-type="fig"}).

The DIP-η homodimers observed in crystals also exist in solution. In size-exclusion chromatography experiments, elution volumes of DIP-η is dependent on the amount of protein loaded on the column ([Figure 5e](#fig5){ref-type="fig"}), which is a strong indication of homodimer formation with a dissociation constant on the order of protein concentrations used in the chromatography experiment, that is micromolar, and a monomer-dimer exchange rate much faster than the timescale of the experiment, which is also compatible with micromolar binding. While size-exclusion chromatography is not an equilibrium experiment, a binding isotherm based on elution peak volumes can be calculated ([Figure 5---figure supplement 1c](#fig5s1){ref-type="fig"}), yielding an apparent *K*~D~ of 11--45 µM, an order of magnitude weaker than the heterodimer. Furthermore, we performed SPR experiments where low density DIP-η surfaces are created to prevent homodimers on chip surface, and data is fit to a binding isotherm while correcting for DIP-η dimerization in solution, yielding a *K*~D~ of 14 µM (see [Figure 5---figure supplement 1d](#fig5s1){ref-type="fig"} and *Materials and methods* for details).

Comparison and engineering of closely related Dpr--DIP heterophilic complexes {#s2-7}
-----------------------------------------------------------------------------

We next set out to compare heterophilic complexes with one common binding partner. We determined the crystal structure of Dpr10 IG1 bound to DIP-α IG1 and compared it to our Dpr6--DIP-α structure ([Figure 6](#fig6){ref-type="fig"}). The IG1 of Dpr6 and Dpr10 are 75% identical in sequence, and the interface only has three residues out of 19 that are different between Dpr6 and Dpr10 ([Figure 6a](#fig6){ref-type="fig"}). The two complex structures closely match each other ([Figure 6b](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1a](#fig6s1){ref-type="fig"}), and unlike the differences among complexes described above, rotamers are nearly all conserved at the two interfaces. The differences in sequence are accommodated by small movements in surrounding side chains and do not propagate further ([Figure 6---figure supplement 1b](#fig6s1){ref-type="fig"}). Overall, these results suggest that Dprs that are highly similar in sequence (≥70% identity) are unlikely to be differentiated in their DIP binding, but in time and place of expression.

![Structural description and engineering of the Dpr10--DIP-α complex.\
(**a**) Comparison of Dpr6 and Dpr10 IG1 sequences. Red boxes indicate Dpr residues within 4 Å of DIP-α in the heterocomplexes. **\*** indicates the three variable residues between Dpr6 and Dpr10 at the interface. (**b**) Side-by-side view of Dpr6--DIP-α and Dpr10--DIP-α complex structures. RMSD values are reported for Cα atoms only. (**c**) N-linked glycan involvement at the Dpr10--DIP-α interface. DIP-α is depicted as a surface colored by electrostatic potential, and Dpr10 is in cartoon representation with the Asn82-linked glycan drawn as sticks. (**d**) Gel filtration chromatography of DIP-α IG1 at three DIP-α concentrations. DIP-α is in a fast-exchange dimer-to-monomer equilibrium in the mid-micromolar range. The chromatograms are drawn at different scales shown to the left of the plot. Path length of the UV flow cell is 0.2 cm. (**e**) ECIA screening of single-site mutants of DIP-α and Dpr10 with modified homophilic and heterophilic affinities. See main text for descriptions of the red, green and orange boxes.](elife-41028-fig6){#fig6}

The high-resolution Dpr10--DIP-α structure also allowed us to observe an ordered, near-complete N-linked glycan at the interface ([Figure 6C](#fig6){ref-type="fig"}). As we use lepidopteran cells to express Dprs and DIPs, the glycan structure and composition in our structure likely match the native insect Dpr/DIP glycans. The structure shows that the first N-acetyl glucosamine (NAG) is fucosylated at both the third and sixth carbon positions -- commonly observed in arthropods but not in mammals. The glycan linked to Asn82 in Dpr10, which is present in seven out of 21 Dprs, is ordered as it inserts itself into a groove on the DIP-α surface, and adds a further 440 Å^2^ area to the buried surface area (total area: 2,240 Å^2^). While the energetic contribution of the glycan is yet to be determined, biochemical studies of Dprs and DIPs may benefit from over-expression in eukaryotic, and specifically arthropod cell lines, due to native-like glycosylation.

During our work with Dpr10 and DIP-α, we detected DIP-α homodimerization with ECIA ([Figure 6e](#fig6){ref-type="fig"}, upper left corner). DIP-α homodimers are also observed via size-exclusion chromatography, similar to DIP-η, in the mid-micromolar range ([Figure 6---figure supplement 1c](#fig6s1){ref-type="fig"}). The heterophilic Dpr6--DIP-α interaction, with a *K*~D~ of 0.37 µM, is stronger than homodimerization of DIP-α, as mixing DIP-α with stoichiometric amounts of Dpr6 creates only heterophilic complexes observable on gel filtration columns, breaking up weaker DIP-α homodimers, and crystal trials including Dpr6 and DIP-α yield heterocomplex crystals ([@bib8]).

As DIP-α and DIP-η can form homophilic and heterophilic interactions, genetic studies using mutations at their binding interfaces cannot unambiguously conclude whether homo- or heterophilic binding activity of these DIPs contribute to the function studied. To create molecular tools that can test the importance of this interface, and to possibly distinguish between both activities, we mutated DIP-α and its binding partner Dpr10 and searched for mutations that preferably break homophilic and/or heterophilic binding ([Figure 6e](#fig6){ref-type="fig"}). Using ECIA, we demonstrated that DIP-α I83A mutant ([Figure 6e](#fig6){ref-type="fig"}, red box) can no longer form homophilic dimers, but still has affinity towards Dpr10 (green box). Titrations using ECIA show that the I83A mutant appears to have a 7.8-fold *higher* affinity for Dpr10 than WT DIP-α ([Figure 6---figure supplement 2a](#fig6s2){ref-type="fig"}). This is in contrast to an expected loss of affinity based on our SPR data: the I83A mutation causes 700-fold loss of binding to Dpr6, which is a close paralog of Dpr10. In the context of a highly oligomerized or clustered distribution of DIP-α molecules, such as in ECIA or at the site of a cellular adhesion, the weak *cis* DIP-α homodimerization will successfully compete with the *trans* heterodimer, depressing heterophilic affinity. DIP-α I83A, which cannot homodimerize, is free to interact with Dpr10, and therefore appears to have high affinity for Dpr10.

Among the mutants tested in the mutational analysis of the Dpr10--DIP-α interface ([Figure 6e](#fig6){ref-type="fig"}), the Dpr10 mutant Y103A abolishes DIP-α binding (orange box), and therefore can be used to study the Dpr10--DIP-α complex function, without effecting DIP-α homodimerization.

Dpr10 and DIP-α in the establishment of neuromuscular circuitry {#s2-8}
---------------------------------------------------------------

The Drosophila larval neuromuscular system consists of 35 motor neurons, which innervate 30 muscles within each hemisegment, forming an invariant circuit that is ideal for delineating genetic mechanisms underlying synaptic connectivity. Although numerous screens and studies have been conducted to uncover potential connectivity molecules ([@bib1]; [@bib5]; [@bib23]; [@bib28]; [@bib30]), we still lack a complete understanding of how a motor neuron chooses its appropriate muscle target(s). This critical gap in knowledge led us to investigate whether Dprs and DIPs have roles in neuromuscular development and specifically in synaptic partner choice. In a prior study, we found that several Dprs and DIPs, including Dpr11 and one of its interacting partners, DIP-γ, were expressed in motor neurons. Importantly, Dpr11 and DIP-γ are required for normal motor neuron terminal growth ([@bib8]). Although the process of neuromuscular junction (NMJ) expansion does not reflect initial synaptic connectivity, the same Dpr--DIP pair is also required for connectivity in the optic lobe. Thus, we delved deeper into Dpr and DIP function at the NMJ.

In the fly larval neuromuscular system, muscles are innervated by multiple motor neurons. The majority of these motor neurons are the class one type, and these can be further subdivided into 1b (big) or 1 s (small) indicative of their terminal, or bouton, sizes. Several additional key factors differentiate 1b and 1 s motor neurons: most 1b motor neurons innervate single muscle targets whereas 1 s motor neurons innervate subgroups of muscles (dorsal, lateral and ventral muscles) and the amount of subsynaptic reticulum (SSR) surrounding 1b boutons is much greater than 1 s. Here we focus on one 1 s motor neuron, the MNISN-1s, that innervates the dorsal muscles ([@bib17]; [@bib22]). In a concurrent study, we demonstrate that *DIP-α* is expressed in MNISN-1s, and a DIP-α binding partner, Dpr10, is expressed postsynaptically in muscles. Importantly, we discovered that these interactors are absolutely required for the proper connectivity between MNISN-1s and the postsynaptic muscle target muscle 4, and partially required for connectivity to muscles 3 and 20 ([@bib4]). Further analysis of a *DIP-α* mutant revealed that the remaining MNISN-1s muscle connections were still present; thus, highlighting the specificity inherent in connectivity codes, even within a single neuron, and the potential requirement for combinatorial interactions between cell surface proteins for establishing synaptic partner matching. As the muscle 4 (m4) connection was the most sensitive to loss of *DIP-α* ([@bib4] and [Figure 7g](#fig7){ref-type="fig"}), we utilized this phenotype to examine if Dprs and DIPs with altered specificities could provide additional insight into our understanding of circuit wiring.

![DIP-α--DIP-α interactions are required for proper MNISN-1s innervation of m4.\
(**a**) *DIP-α* is expressed in MNISN-1s (green) neurons. The *DIP-α-GAL4* allows for utilization of the UAS/GAL4 system and this gene trap is also a null allele ([@bib4]). In *DIP-α-GAL4* heterozygous (het) larvae, both 1b (arrowhead) and 1 s (arrow) terminals are present on m4. (**b**) Removal of *DIP-α* results in loss of MNISN-1s innervation of m4. The MNISN-1s axon is still visible (green) and continues to innervate other dorsal muscles. These hemizygous male larvae retain *GAL4* expression under the control of the endogenous *DIP-α* promoter. (**c**) Overexpression of UAS-*DIP-α*-Myc (shortened to UAS-*DIP-α*) does not affect innervation of m4 in a heterozygous *DIP-α-GAL4* background. DIP-α localizes to the 1 s terminals (green in inset; [@bib4]). Note that DIP-α protein is labeled with anti-Myc. Green signal on muscles represents non-specific labeling of anti-Myc (see [Figure 7---figure supplement 1e](#fig7s1){ref-type="fig"}). (**d**) The *DIP-α* loss-of-function phenotype is rescued by reintroducing a UAS-*DIP-α* transgene in cells that normally express DIP-α. (**e**) UAS-*DIP-α^I83A^* expression does not alter innervation of m4 and DIP-α^I83A^ localizes normally within the 1 s terminals (inset). (**f**) Expression of UAS-*DIP-α^I83A^* fails to rescue the *DIP-α* loss-of-function phenotype (no 1 s innervation of m4). (**g**) Quantification of 1 s innervation of m4. Heterozygous background contains a single wild-type copy of *DIP-α*, while the hemizygous background only contains the loss-of-function allele. Expression of UAS-*DIP-α* completely rescues the loss-of-function phenotype, while expression of the UAS-*DIP-α^I83A^* does not. Control UAS transgene background (no GAL4) does not affect m4 innervation. n: See [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}. \*\*\*p\<0.0001. Calibration bar, 10 μm.\
10.7554/eLife.41028.021Figure 7---source data 1.Source data for [Figure 7---figure supplement 1a, b and f](#fig7s1){ref-type="fig"}.\
10.7554/eLife.41028.022Figure 7---source data 2.Source data for [Figure 7g](#fig7){ref-type="fig"}.](elife-41028-fig7){#fig7}

In addition to the two DIP-α binding partners, Dpr6 and Dpr10, observed in the first application of the ECIA strategy ([@bib32]), we have demonstrated here the DIP-α homophilic binding ([Figure 6e](#fig6){ref-type="fig"}). This new interaction raised the important question: Is DIP-α homodimerization required for proper wiring of the neuromuscular system? In our concurrent study, we showed that removal of *DIP-α* leads to the lack of MNISN-1s innervation of m4 ([@bib4] and [Figure 7a,b,g](#fig7){ref-type="fig"}). We used a *DIP-α-GAL4* gene trap which serves the dual purpose of a loss-of-function (LOF) allele and a GAL4 driver in the bipartite GAL4/UAS system. Also, these studies take advantage of *DIP-α* being an X-linked gene since *DIP-α-GAL4* heterozygous females can be used as controls and hemizygous males represent null mutants. Utilizing this approach, we can rescue the LOF *DIP-α* phenotype by expressing a wild-type UAS-*DIP-α* in cells which normally express *DIP-α*, including MNISN-1s ([@bib4] and [Figure 7d,g](#fig7){ref-type="fig"}). We favor a model whereby transsynaptic Dpr10--DIP-α interactions mediate connectivity, which we set out to demonstrate using single-site mutations that break the interaction. For this purpose and to tease apart roles for homophilic and heterophilic interactions, we constructed a *DIP-α* mutant I83A (*DIP-α^I83A^)* which abolishes homophilic binding but does, at least partly, retain the Dpr10 interaction ([Figure 6e](#fig6){ref-type="fig"} and [Figure 6---figure supplement 2a](#fig6s2){ref-type="fig"}). As shown in [Figure 7d and g](#fig7){ref-type="fig"}, expression of UAS-*DIP-α* in cells that normally express DIP-α is able to rescue the loss of *DIP-α* phenotype confirming our previous finding. However, when the same experiment is repeated with UAS-*DIP-α^I83A^*, we no longer observe rescue ([Figure 7f,g](#fig7){ref-type="fig"}), suggesting that the DIP-α interaction interface we identified is required for the connectivity of MNISN-1s to m4, and that the connectivity might depend on homodimerization activity of DIP-α. These results are not due to changes in DIP-α^I83A^ expression since the mutant and wild type DIP-α are expressed at similar levels ([Figure 7---figure supplement 1a](#fig7s1){ref-type="fig"}). Also, to confirm that there are no inherent sex differences in the formation of these terminals, we scored female and male heterozygous transgene controls and found no significant differences in m4 innervation ([Figure 7---figure supplement 1b](#fig7s1){ref-type="fig"}). Overall, this suggests a multistep process of m4 innervation requiring both a Dpr10--DIP-α interaction as well as a homomeric DIP-α--DIP-α interaction.

In our concurrent study describing the role of Dpr10--DIP-α interactions in wiring of the neuromuscular circuit, we found that overexpression of UAS-*dpr10* in muscles caused the partial loss of MNISN-1s innervation of m4, similar to the *dpr10* mutant phenotype ([@bib4]). We sought to determine if this gain-of-function (GOF) phenotype was a direct consequence of overexpressed Dpr10 interacting with endogenous DIP-α. As discussed above, the Dpr10 mutant Y103A (hereafter denoted *Dpr10^Y103A^*) is unable to bind DIP-α ([Figure 6e](#fig6){ref-type="fig"}), providing an ideal tool for exploring this GOF phenotype. Unlike muscle overexpression of UAS-*Dpr10* ([Figure 8a](#fig8){ref-type="fig"}), similar high level expression of UAS-*dpr10^Y103A^* in muscles does not affect MNISN-1s innervation of m4 ([Figure 8b,c](#fig8){ref-type="fig"}), suggesting that the Dpr10--DIP-α interaction is an integral component of the Dpr10 GOF phenotype. This GOF phenotype is dependent on the levels of UAS-*dpr10* overexpression, as mild muscle expression does not reveal the GOF phenotype ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). To address the possibility of an unexpected downstream effect of the Dpr10^Y103A^ mutant, we showed that the Y103A mutation does not affect the interaction of Dpr10 with cDIP ([Figure 6---figure supplement 2b](#fig6s2){ref-type="fig"}); however, we cannot rule out effects mediated by unknown binding partners of Dpr10. Furthermore, we reasoned that if overexpressed Dpr10 is acting through DIP-α, partial loss of *DIP-α* should exacerbate the GOF UAS-*dpr10* phenotype while overexpression of UAS-*dpr10^Y103A^* should be insensitive to DIP-α levels. Indeed, only overexpression of UAS-*dpr10* is sensitive to DIP-α levels ([Figure 8c](#fig8){ref-type="fig"}), supporting a role for endogenous DIP-α interaction with overexpressed Dpr10.

![DIP-α is required for the loss of MNISN-1s innervation of m4 when overexpressing Dpr10 postsynaptically.\
(**a**) Loss of MNISN-1s innervation of m4 due to overexpression of UAS-*dpr10-V5* (referred to in the figure as UAS-*dpr10*) in muscles with the *Mef2-GAL4* driver. Dpr10 is localized specifically to the postsynaptic membrane (green) and co-localizes with Dlg, a postsynaptic membrane marker (red). Anti-HRP (blue) labels all neuronal membrane. (**a~1~**) and (**a~2~**) show the individual Dpr10 and Dlg channels, respectively. Note that only 1b terminals are present. Also, the Dpr10 protein is labeled with anti-V5. (**b**) Muscle overexpression of a Dpr10 variant (UAS-*dpr10^Y103A^*) that is incapable of binding DIP-α does not affect m4 innervation. Both 1b and 1 s (arrow) terminals are present on m4. The 1b and 1 s terminals are easily distinguished by size and staining intensity of Dlg (**b~2~**) (see *Materials and methods*). (**c**) Quantification of 1 s innervation of m4. Overexpression of wild type UAS-*dpr10* transgene results in 25% of m4s innervated by MNISN-1s compared to 89% innervation when overexpressing UAS-*dpr10^Y103A^* which is unable to bind DIP-α. n: See [Figure 8---source data 1](#fig8sdata1){ref-type="supplementary-material"}. \*\*\*p\<0.0001. Calibration bar, 10 μm.\
10.7554/eLife.41028.025Figure 8---source data 1.Source data for [Figure 8c](#fig8){ref-type="fig"}.\
10.7554/eLife.41028.026Figure 8---source data 2.Source data for [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}.](elife-41028-fig8){#fig8}

Discussion {#s3}
==========

Recent advances in connectomics and transcriptomics have the potential to enhance our mechanistic understanding of neuronal wiring, especially if such datasets can be matched by accurate neuronal protein interaction datasets, and a structural and evolutionary understanding of how common molecular tools across animal taxa have been repeatedly used, and regularly expanded to create more complex neuronal networks. Previous evidence shows that Dprs and DIPs may be representative of neuronal surface proteins that have expanded in the arthropod line to help wire complex but stereotyped brains.

The interaction network created by the Dprs and DIPs demonstrates how gene duplication events have led to diversity in molecular recognition and function in neuronal surface molecules. While the distant gene duplication events have given rise to the five Dpr and five DIP subclasses and have resulted in specialization of interactions, the more recent duplication events have only created mostly redundant molecular interactions. A comprehensive analysis of other arthropod Dprs and DIPs may reveal evolutionary forces that have resulted in repeated gene duplications in these families, and it is intriguing to speculate that the complexity of neural networks and the numbers of Dprs, DIPs and other neuronal surface receptors may correlate in arthropod species.

The Dpr and DIP complex structures we have determined show a two-fold pseudo-symmetric architecture. Here, we also show the presence of DIP-η and DIP-α homodimers in solution and present a symmetrical DIP-η homodimer structure that closely mimics heterodimeric Dpr--DIP complexes. This raises the question of whether the homophilic or the heterophilic interaction evolved first. Since Dpr and DIP IG1 sequences can be aligned with identities well above any random IG domain sequences, and Dpr and DIP IG1 domains are nearly identical in structure (RMSD values ≤ 1 Å), we believe that Dpr and DIP IG1 domains may be the result of an ancient duplication event of a homodimeric IG domain. Following this logic, the DIP-η and DIP-α complexes may represent homodimers that were retained through multiple gene duplications. As heterophilic binding allows for higher diversity in neuronal recognition than homophilic would (i.e. 21 × 9 possible heterodimers \> 30 possible homodimers), heterophilic binding must have been favored for specifying neuronal connections in complex structures such as the fly optic lobe. This is corroborated by our observations that heterodimers have higher affinities than the homodimers.

The observations we report here, including the lack of intracellular regions and the flexible nature of the ectodomain, have led us to believe that Dprs and DIPs may not be signaling receptors, and would require binding to co-receptors or secreted ligands for relaying signal to the cytoplasm upon formation of homo or heterodimers. It is also unclear if *cis* dimers can form, and signal. As *cis* dimers would inhibit productive *trans* cell-adhesive structures, their presence has significant functional relevance. We believe that interdomain flexibility and long low-complexity 'stalk' regions linking the IG domains to the membrane would enable *cis* dimerization for homodimeric DIPs, such as DIP-α and DIP-η. In fact, our SPR experiments where DIP-η is captured on solid support at high densities reports much higher apparent *K*~D~ values for the Dpr1--DIP-η interaction (23 µM vs 4.0 µM measured when non-dimerizing Dpr1 is captured on SPR chip; [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"},[3](#fig4s3){ref-type="fig"}), as the *cis* DIP-η homodimer formation on the chip likely competes with Dpr1 binding. The *cis* homodimerization may actually be the result of a strategy to inhibit cellular adhesions resulting from relatively weak *trans* interactions, which would not be able to overcome the *cis* homodimers. This would lead to more stringent selectivity for intercellular interactions, and would prevent non-specific synapses. We examined these interactions using engineered mutations in the NMJ, and found evidence for functional relevance for both *cis* homodimeric and *trans* heterodimeric interactions, supporting our view.

The requirement of the homomeric DIP-α--DIP-α interaction for proper synaptic targeting presents a layer of complexity to what at first appearance was a straightforward binary model. We now know that DIP-α is required for proper synapse wiring, as a wild type UAS-*DIP-α* transgene in the mutant background can restore connectivity. However, when we introduce a UAS-*DIP-α* transgene with a mutation that breaks the DIP-α--DIP-α interaction in the same mutant background, the mutant form is unable to rescue the loss of connectivity. This does not appear to be a trafficking defect, as DIP-α^I83A^ appears at similar wild-type levels in 1 s terminals as it does on other muscles ([Figure 7---figure supplement 1c,d](#fig7s1){ref-type="fig"}). DIP-α^I83A^ binds Dpr10, so we cannot rule promiscuous binding of DIP-α^I83A^ to Dpr10 on other muscles; however, overexpression of UAS-*DIP-α^I83A^* with either *DIP-α-GAL4* or *Eve-GAL4*, which also drives in MNISN-1s, does not reveal a GOF phenotype ([Figure 7---figure supplement 1f](#fig7s1){ref-type="fig"}). Instead, our data support a model in which weak *trans* interactions with other molecules are resisted by homodimeric DIP-α complexes. This mode of targeting would allow for motor neuron growth cones to bypass non-specific or very weak interactions on non-target muscles and only synapse on bona-fide muscle targets. Interestingly, our concurrent study demonstrates that Dpr10 is expressed in specific muscles during embryonic development synchronous with growth cone exploration of those muscles, and thus overcome DIP-α homodimerization in favor of the stronger Dpr10--DIP-α heterodimer.

*Note added in proof:* During the late revision stages of our manuscript, two articles from the Shapiro, Honig and Zipursky groups were published ([@bib10]; [@bib43]). The results in our manuscript and the accompanying manuscript ([@bib4]) are in general agreement. The structures presented here and in Cosmanescu et al. show a conserved mode of binding, now observed crystallographically across three DIP homodimers and five Dpr--DIP heterodimers. The conservation of the hydrophobic core and the variable polar periphery is another shared observation. The amino acids chosen to disrupt DIP-α and Dpr10 complexes, DIP-α I83 and Dpr10 Y103, were common to both studies. Finally, both sets of studies demonstrate phenotypes when DIP-α homodimers or Dpr10--DIP-α heterodimers are affected via mutagenesis.

One point of difference is in the SPR-measured affinities of heterophilic Dpr--DIP complexes. Our reported *K*~D~ values for the Dpr6--DIP-α, Dpr11--DIP-γ and Dpr1--DIP-η interactions are 6, 7, and 21-fold lower (i.e. interactions are stronger), respectively, than those of Cosmanescu et al., and as a result, these heterodimer affinities are much stronger than the homodimer affinities reported by both manuscripts. We do not believe that the disparities for heterodimeric affinities are due to the presence of additional IG domains included in SPR experiments in Cosmanescu et al., since these domains do not contribute structurally and energetically to binding as we have demonstrated initially via SPR in [@bib8]. Instead, we show that DIP homodimer formation may cause SPR experiments to underestimate heterodimeric affinities (i.e. over-report *K*~D~ values) due to competition between the two modes of binding, which we endeavored to remedy in our study. The interactions we identified with ECIA for DIP-ζ, -η and -θ which were not detected in Cosmanescu et al. may have been affected by this artifact during SPR experiments. The measurement of accurate affinities at overlapping homo- and heterophilic binding sites remains a significant challenge, including for Dprs and DIPs.

Materials and methods {#s4}
=====================

Phylogenetics {#s4-1}
-------------

The regions containing immunoglobulin domains from the *D. melanogaster* Dpr and DIP sequences were aligned using MUSCLE ([@bib11]). The phylogenetic analysis was performed using PhyML ([@bib16]) and the phylogenetic trees were drawn with SeaView ([@bib14]).

Protein expression and purification {#s4-2}
-----------------------------------

All large-scale Dpr and DIP protein expression was done using the baculoviral expression system. Constructs were cloned into the baculoviral transfer vector pAcGP67A (BD Biosciences) and its variants, followed by co-transfection with linearized BestBac 2.0 baculoviral DNA (Expression Systems, 91--002) into Sf9 cells, using Trans-IT Insect (Mirus Bio) or Cellfectin II (Thermo Fisher, 10362--100) as the transfection reagent according to manufacturers' specifications. For protein expression, High Five cells (BTI-TN-5B1-4) grown in Insect-XPRESS (Lonza, 12-730Q) were infected at 2 × 10^6^ cells/ml density, and conditioned media were collected at 48--66 hr post-infection for purification of secreted proteins. All proteins expressed were designed to have C-terminal hexahistidine tags for purification via immobilized metal affinity chromatography.

Proteins were purified from the media using a protocol that precipitates unknown metal chelators in media by adding 50 mM Tris pH 8.0, 5 mM CaCl~2~ and 1 mM NiCl~2~, followed by removal of the precipitate and batch pull-down of Dprs and DIPs via Ni-NTA Agarose beads (QIAGEN, catalog no. 30250). All proteins were further purified on size-exclusion columns (GE Healthcare), Superdex 75 10/300 for single-domain constructs and Superdex 200 Increase 10/300 for two- or three-domain constructs, and buffer exchanged into the final buffer, HEPES-buffered saline or HBS (10 mM HEPES, pH 7.2, 150 mM NaCl).

Proteins that need to be captured on streptavidin coated SPR chips were produced with C-terminal Avi- and His-tags. The Avi-tagged proteins were biotinylated after protein purification using BirA biotin ligase, followed by a second size-exclusion chromatography step.

Size-exclusion chromatography of Fast-Exchange DIP homodimers {#s4-3}
-------------------------------------------------------------

DIP homodimers can be observed on small-zone size-exclusion (gel filtration) chromatography (SEC) runs. Due to fast kinetics of association and dissociation, homodimerizing DIPs run as single peaks in these chromatography runs, as the timescale of the chromatography experiment (minutes to an hour) is much longer than the timescales of monomer-dimer conversions (1 second or less) as observed in SPR experiments (Stevens, 1989; Wilton et al., 2004). While there is no explicit mathematical model for small-zone SEC for fast-kinetics oligomers (Stevens, 1989), simulations can accurately predict elution profiles. Here, we make simplifications to plot binding isotherms: (1) we ignore diffusion and dispersion terms, (2) and that the elution position is given by the peak's highest point. Based on observed dimer and monomer elution velocities, measured elution volumes can be converted to dimer fraction: Since the flow rate and the column volume is constant, 'velocity' can be thought as (Elution volume)^---1^. Therefore, the elution volume of a mixed monomer-dimer sample will be,$${V_{elution,\ mixed}}^{- 1} = f_{dimer} \times \left( V_{elution,\ dimer} \right)^{- 1} + \left( {1 - f_{dimer}} \right) \times \left( V_{elution,\ monomer} \right)^{- 1}$$which gives the dimer fraction, $f_{dimer}$.

Protein concentration vs. dimer fraction was fit to a binding isotherm with the following formula in MATLAB:$$f_{dimer} = \frac{2\left\lbrack Dimer \right\rbrack}{2\left\lbrack {Dimer} \right\rbrack + \left\lbrack Monomer \right\rbrack} = \frac{4\left\lbrack DIP \right\rbrack_{total} + K_{D} - \sqrt{{K_{D}}^{2} + 8K_{D}\left\lbrack DIP \right\rbrack_{total}}}{4\left\lbrack DIP \right\rbrack_{total}}$$

Due to simplifications and assumptions as mentioned above, and especially uncertainties in pure dimer and monomer elution volumes, we choose to provide a range, rather than a single *K*~D~ value in the main text. Dissociation constant estimated from gel filtration profiles for DIP-η (23 µM) proved to be within 1.6-fold of the dissociation constant measured with SPR (14 µM) showing the utility of the method ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Protein crystallization and structure determination {#s4-4}
---------------------------------------------------

Proteins were crystallized using the sitting-drop vapor diffusion method with a Mosquito robot (TTP Labtech) at 21°C, using 100 nl protein +100 nl crystallant drops against 50 µl crystallant reservoir. Proteins used for crystallization were dissolved in HBS, unless noted otherwise.

*Dpr11--DIP-γ.* Crystals for the complex of Dpr11 IG1 with DIP-γ IG1 +2 were grown from 15 mg/ml protein sample using 0.1 M sodium citrate, pH 5.5, 2 M ammonium sulfate. Crystals were cryo-protected in 0.1 M sodium citrate, pH 5.5, 2.2 M ammonium sulfate, 30% glycerol and vitrified in liquid nitrogen. X-ray diffraction data were collected at the Advanced Photon Source, beamline 23-ID-B. Crystallographic data were reduced using *XDS* ([@bib18]), and the structure was determined by molecular replacement with *PHASER* ([@bib25]) using Dpr6 and DIP-α structures (PDB ID: 5EO9). Model refinement and building were performed with *phenix.refine* ([@bib3]) and *Coot* ([@bib12]). For model validation, we used tools in the *PHENIX* ([@bib2]) suite, specifically provided by *Molprobity* (*[@bib9]*) and *Coot*.

*Dpr1--DIP-η.* Crystals for the complex of Dpr1 IG1 with DIP-η IG1 were grown from 16 mg/ml protein sample in 10 mM HEPES pH 7.2, 350 mM NaCl, using 0.2 M lithium sulfate, 0.1 M MES, pH 6, 20% (w/v) PEG 4000. Crystals were cryo-protected in 0.15 M ammonium sulfate, 0.1 M MES, pH 5.5, 25% (w/v) PEG 4000, 25% glycerol and vitrified in liquid nitrogen. X-ray diffraction data were collected at the Advanced Photon Source, beamline 23-ID-D. Crystallographic data were reduced using *HKL2000* ([@bib31]). Molecular replacement, model refinement, building and validation were performed as above.

*DIP-γ only.* Crystals for DIP-γ IG1 +2 were grown from a 1:1 mixture of DIP-γ and cDIP at 15 mg/ml protein sample in the crystallant 0.15 M ammonium sulfate, 0.1 M MES, pH 5.5, 25% (w/v) PEG 4000. Crystals were cryo-protected in 0.15 M ammonium sulfate, 0.1 M MES, pH 5.5, 25% (w/v) PEG 4000, 25% glycerol and vitrified in liquid nitrogen. X-ray diffraction data were collected at the Advanced Photon Source, beamline 24-ID-E. Crystallographic data were reduced using *XDS* ([@bib18]). Molecular replacement, model refinement, building and validation were performed as above.

*DIP-η homodimer.* Crystals for DIP-η IG1 homodimers were grown from a with 20 mg/ml protein sample in the crystallant 0.1 M sodium citrate, pH 5.5, 45% (w/v) PEG 200. Crystals were cryo-protected in 0.1 M sodium citrate, pH 5.2, 50% (w/v) PEG 200 and vitrified in liquid nitrogen. X-ray diffraction data were collected at the Advanced Photon Source, beamline 24-ID-E. Crystallographic data were reduced using *XDS*. Molecular replacement, model refinement, building and validation were performed as above.

*Dpr10--DIP-α.* Crystals were grown from a 1:1 mixture of Dpr10 IG1 and DIP-α IG1 with 15 mg/ml protein sample in the crystallant 1 M lithium chloride, 0.1 M HEPES, pH 7.0, 20% (w/v) PEG 6000. Crystals were cryo-protected in 0.2 M lithium chloride, 0.1 M Tris, pH 8.0, 22% (w/v) PEG 6000, 25% glycerol and vitrified in liquid nitrogen. X-ray diffraction data were collected at the Advanced Photon Source, beamline 23-ID-B. Crystallographic data were reduced using *XDS*. Molecular replacement, model refinement, building and validation were performed as above.

Analysis of the interaction interfaces were aided by *PyMOL* (Schrödinger LLC) and *PISA* ([@bib21]). RMSD calculations were done in PyMOL for all Cα atoms in each IG1 domain with zero outlier rejections. Buried surface areas are reported in the text as interface areas from each polypeptide chain combined.

Surface Plasmon Resonance {#s4-5}
-------------------------

Most SPR experiments were performed, as before ([@bib8]), on a Biacore T200 using Streptavidin-coated (SA) chips from GE Healthcare. The DIP-η homodimerization experiments were performed with a Biorad ProteOn XPR36 using the low-capacity Neutravidin chips. For mutants with high dissociation constants (usually \>100 µM), maximum response (*R*~max~) values could not be determined. In such cases, estimates of dissociation constants were calculated while constraining *R*~max~ to well-determined values measured on the same channel from wild-type measurements. All buffers included the surfactant 0.05% Polysorbitan-20 to prevent non-specific binding. Fitting to binding isotherms were done in BIAEvaluation (GE Healthcare), Prism 6 (GraphPad) or MATLAB (Mathworks) using 1:1 Langmuir binding models.

Affinity measurement for homodimeric proteins by SPR are complicated by the fact that homodimers form between analyte and ligand (on the chip), between ligand and ligand (on the chip), and between analyte and analyte (in the mobile phase). To avoid ligand-ligand homodimerization on the chip, we created a SPR chip by loading it with dilute (i.e. monomeric) DIP-η and only sparsely populated a low-capacity Neutravidin chips, approximately 100 response units on the ProteOn XPR36 system. To account for homodimerization of DIP-η molecules in the mobile phase, we assumed that free, unbound DIP concentration,$$\left\lbrack DIP \right\rbrack_{free} = \left( {- K_{D} + \sqrt{{K_{D}}^{2} + 8K_{D}\left\lbrack DIP \right\rbrack_{total}}} \right)/4$$and we fit the binding isotherm to$$f_{bound} = \frac{Response}{R_{max}} = \frac{- K_{D} + \sqrt{{K_{D}}^{2} + 8K_{D}\left\lbrack DIP \right\rbrack_{total}}}{3K_{D} + \sqrt{{K_{D}}^{2} + 8K_{D}\left\lbrack DIP \right\rbrack_{total}}}$$

In MATLAB, yielding a *R*^2^ value of 0.97 for the fit ([Figure 5---figure supplement 1d](#fig5s1){ref-type="fig"}).

Extracellular interactome assay (ECIA) {#s4-6}
--------------------------------------

The assay was performed according to [@bib32]. One modification to the assay was the use of a higher-expressing promoter, the constitutively active Actin5C promoter, in the S2 expression plasmids, which we believe to have resulted in higher sensitivity for the assay, and the detection of the homophilic DIP-α complex. Before performing the assay, proteins, bait and prey, were western blotted and detected using an anti-penta-His antibody coupled to iFluor488 (Genscript, A01800), and protein concentrations for any wild-type +mutant set were normalized via dilution.

Fly strains {#s4-7}
-----------

  Fly strain              Source
  ----------------------- --------------------------------------------
  *w^1118^*               Bloomington Drosophila Stock center (BDSC)
  *Mef2-GAL4*             Gift of Hugo Bellen
  *DIP-α-T2A-GAL4*        Gift of Hugo Bellen
  *DIP-α^1-178^*          Gift of Lawrence Zipursky
  UAS-*DIP-α*-Myc         Gift of Lawrence Zipursky
  UAS-*DIP-α^I83A^*-Myc   See below
  UAS-*dpr10*-V5          Gift of Lawrence Zipursky
  UAS-*dpr10^Y103A^*-V5   See below
  UAS-2XEGFP              BDSC \#6874
  24B*-GAL4*              BDSC \#1767
  *Eve^RN2^-GAL4*         BDSC \#7470
  BG487-*GAL4*            BDSC \#51634

*Drosophila* genetics {#s4-8}
---------------------

The *DIP-α-T2A-GAL4* gene trap line is a null allele for *DIP-α*. As *DIP-α* is an X-linked gene, hemizygous males are *DIP-α* nulls. Female *DIP-α-T2A-GAL4* flies were crossed to UAS transgenic male flies, such that all male progeny are hemizygous for *DIP-α-T2A-GAL4* and all females are heterozygous. For controls, wildtype females (*w^1118^*) were crossed to the same UAS transgenic males. The other GAL4 lines are not located on the X chromosome so the F1 gender had no impact on experimental outcome.

Generation of transgenic lines {#s4-9}
------------------------------

Plasmid constructs were generated by PCR amplification of existing genomic DNA sequences from the UAS-*DIP-α*-Myc and UAS-*dpr10*-V5 fly lines (gifts of Lawrence Zipursky). Both were amplified using the common primers: AATAGGGAATTGGGAATTCAGATCTAAAAGGTAGGTTCAACCAC and GAGTTCTGTGTGTATAACAAATGCTG. Using site directed mutagenesis, the point mutations were introduced into DIP-α using the following primers (lowercase represents the primer mismatch): ACCAAGGCCgcTCAAGCCATCCACGAGAACGTA and AAGGCCGACACCAAGGCCgcTCAAGCCAT. The following primers were used to introduce mutations into Dpr10: ACCAAGGCCgcTCAAGCCATCCACGAGAACGTA and AAGGCCGACACCAAGGCCgcTCAAGCCAT. The resulting products were cloned into pUASTattB using Gibson Assembly (New England Biolabs). The resulting plasmids were sent for injection (Genetivision) and inserted into attP2 (*DIP-α*^I83A^-Myc) and VK20 (*dpr10*^Y103A^-V5). Once established, these lines were then crossed to DIP-α-GAL4 (gift of Hugo Bellen) or Mef2-GAL4 (Bloomington Drosophila Stock Center), respectively.

Antibodies used {#s4-10}
---------------

  Antibody                    Concentration   Source
  --------------------------- --------------- --------------------------------------------------------
  Goat anti-HRP-TRITC         1:50            Jackson Immunological Research (Jackson) \#123-025-021
  Goat anti-HRP-Alexa405      1:50            Jackson \#123-475-021
  Mouse anti-Dlg              1:100           Developmental Studies Hybridoma Bank (DSHB) \#4F3
  Mouse anti-V5               1:400           ThermoFisher \#R960-25
  Rabbit anti-GFP             1:1000          ThermoFisher \#A11122
  Rabbit anti-Dlg             1:40,000        Gift of Vivian Budnik ([@bib41])
  Rabbit anti-Myc             1:200           Cell Signaling Technology \#71D10
  Goat anti-Mouse-Alexa488    1:500           ThermoFisher \#A11029
  Goat anti-Mouse-Alexa568    1:500           ThermoFisher \#A11031
  Goat anti-Mouse-Alexa647    1:500           ThermoFisher \#A21235
  Goat anti-Rabbit-Alexa488   1:500           ThermoFisher \#A11008
  Goat anti-Rabbit-Alexa568   1:500           ThermoFisher \#A11036

Larval sample preparation and quantification {#s4-11}
--------------------------------------------

Wandering third instar larvae were dissected as per Menon and Zinn ([@bib26]). Briefly, samples were dissected on Sylgard dishes (Dow) under phosphate buffered saline (PBS: 10 mM phosphate buffer, 150 mM sodium chloride) and fixed for 30 min in 4% paraformaldehyde (1:5 dilution of 20% paraformaldehyde (Electron Microscopy Sciences) in PBS). Samples were permeabilized using PBS containing 0.05% Triton-X100 (PBST), washed three times, 15 min each, with PBST and incubated with primary antibodies overnight. Samples were washed three times, 15 min each, in PBST and then incubated in secondary antibodies (see above) for two hours. Samples were finally washed in PBST and then mounted in vectashield antifade reagent (Vector Laboratories). The presence or absence of 1 s innervation was determined using a Zeiss Axioimager equipped with a 40X plan-neofluar 1.3NA objective. The differential DLG labeling, weaker in type 1 s boutons compared to 1b boutons ([@bib15]), allowed for detection and quantification of 1b and 1 s boutons on muscle 4. Abdominal segments A2-A4 were examined for each animal, and then pooled into the final quantification. Statistical analysis was performed using a student's T-test for pairwise comparison of genotypes using Prism software (Graphpad). For multiple comparisons, statistics were performed using one-way ANOVA with Dunnett's post hoc.

Microscopy and image analysis {#s4-12}
-----------------------------

Confocal microscopy was performed on a Zeiss LSM800 confocal microscope using either a 40X/1.3NA plan-neofluar objective, or a 63 × 1.4 NA plan-apo objective. Experiments performed on the same day were imaged together using identical settings.

Analysis of immunofluorescence intensity was performed using ImageJ (NIH) software. For each section of an arbor, exactly 11 confocal slices were z-projected using the sum z-projection algorithm. The HRP signal was thresholded using the Huang setting in ImageJ to outline the boutons. The mean fluorescence signal was determined using the measure function. This value was normalized to w^1118^ control samples which were processed and imaged on the same day as the overexpression experiments to account for non-specific anti-Myc labeling. Finally, the normalized intensity values of DIP-α and DIP-α^I83A^ were expressed as a percentage of DIP-α. A Student's *t*-test was run between the two data sets, and no significant difference was found.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Molecular Basis of Synaptic Specificity by Immunoglobulin Superfamily Receptors in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by Eve Marder as the Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript presents a structural study of proteins from the immunoglobulin superfamily, Dprs and DIPs, which have been reported to regulate synaptic connectivity in the *Drosophila* central and peripheral nervous systems. The authors use evolutionary, biophysical and biochemical approaches to analyze sequence similarities and differences in specific regions of Dpr/DIP heterophilic complex, including the hydrophobic core, in order to evaluate binding specificity after mutating amino acids at the interface. The authors also compare the structure of a homodimer of DIP with heterodimers between DIP and Dpr. They generate multiple variants that selectively abolish homodimerization of DIP-α, or the formation of heteromeric complexes of DIP-α with Dpr10. Using the *Drosophila* larval neuromuscular junction as a model, the authors conduct in vivo studies to further test the roles of DIP-α/Dpr10 complexes and DIP-α homodimers in neuromuscular circuit wiring. The authors highlight the function of cis-dimers of DIPs in regulating synaptic wiring, on top of the reported heterodimeric trans interactions between DIPs and Dprs.

The structural studies are extensive and outstanding and will provide useful information for the research community focusing on proteins containing immunoglobulin domains. While the quality of the structures data and analyses is generally high, the in vivo study of DIP-α/Dpr10 should be improved to better support the conclusions as outlined below.

Essential revisions:

Overall

It would greatly strengthen the work to more clearly highlight what the novel aspects are. What do we now know that we did not know before about how the DPR:DIP system works? Several strategic sentences placed throughout the text would be very helpful for the reader.

In vivo experiments

Some alternative explanations for the Dpr10 / DIP-α mutants need to be considered: what evidence exists that the only defect in Y103A is its interaction with DIP-α? The data suggest the authors\' preferred model IF there are no other defects in the function / ability to interact with other downstream molecules of this particular Dpr10 mutant. Is this true? If this evidence does not exist, the authors should at least highlight that possibility more clearly. A similar argument for DIP-α I83A- the mutation removes some of the interaction ability with Dpr10. How can the authors ensure that this removal doesn\'t also affect the system? What if the phenotype is sensitive to Dpr10 interaction levels? Though these may be the most parsimonious explanations, they have not been conclusively shown by the data and more information should be offered or an appropriate scaling back of the conclusions and recognition of alternate explanations should be made.

The NMJ studies lack certain controls and experiment information -- especially in Figure 7 and Figure 8, the data lack a wild-type control, a base loss-of-function to evaluate the phenotype, and sample sizes for all experiments. For instance, a Gal4 control or the control with UAS single transgene background should be added. What is Is innervation of muscle 4 normally? Does the heterozygous condition cause a partial phenotype? Or is that normal? Further, the authors cite that Dlg staining is used to tell the difference between Ib and Is boutons, but Figure 8A has no Dlg staining. This should be included. Though Ashley et al., is cited, it is not vetted by peer review. Therefore, additional data are needed here to assess the phenotype.

The interpretation of the results in Figure 7 is confusing. The evidence about the requirement of DIP-α\'s for proper targeting of MNISN-1s boutons appears later in Figure 8A,B. This reverse order makes the interpretation hard to follow in Figure 7. The authors should re-arrange the figures.

The authors do not show the effects of gain-of-function of Dpr10 or its variants in the muscle in a DIP-α hemizygous mutant background. This is the direct evidence to suggest that DIP-α is required for the loss of MNISN-1s boutons when overexpressing Dpr10. More appropriately, the authors should mutate endogenous Dpr10 to a form that does not bind to DIP-α, and test if MNISN-1s boutons are lost. The negative results after gain-of-function of a Dpr10 variant only suggest that an excessive amount of this Dpr10 variant is insufficient to affect 1s bouton targeting.

In Figure 7, a single muscle driver *Mef2*-Gal4 was used to overexpress the Dpr10-V5 and its variant, and the quantification in Figure 7C suggests that it leads to an increase of 1s bouton innervating m4. Using independent lines with stronger or weaker expression than *Mef2*-Gal may result in different outcomes and hence, might provide more information about the effects of overexpression of Dpr10 variants.

Could 1s bouton sizes and numbers be quantified to compare with wild type in Figure 7 and Figure 8? These may provide additional information about the functional influence of DIP/Dpr interactions.

A concern in Figure 8E and 8F is that UAS-DIP-α I83A may not function at all in vivo, as only negative results are reported in the paper using this transgene. Testing the effect on 1s boutons after overexpressing DIP-α I83A in a wild type background would be a way to evaluate the functional role of this variant. The expression level of DIP-α after overexpression of DIP-α I83A could also be tested for a comparison with the wild type.

Figure 7 and Figure 8. It would be helpful to indicate in the legends how many m4s were analyzed and quantified (Figure 7C and Figure 8G).

Overall, the NMJ section is written such that particular aficionados will understand it, but few others will. The authors should present a more general assessment, offering more to discuss the difference between type Ib and Is boutons (this knowledge is mostly taken for granted in the current version), and describe the DIP / Dpr reagents used (key amongst being the knowledge of what DIP-α-GAL4 is and that it is also an allele -- this was unclear unless you have intimate familiarity with exactly what reagents the authors are employing). This will aid in accessibility, understanding, and proper assessment by the field of the story.

Presumably if they\'re looking at heterozygous versus hemizygous, this gene is on X, so the two larvae being compared are male and female. Is this appropriate? Are there any inherent sex differences in any of these terminals that could confound this interpretation?

Please include more detail in *Drosophila* genetics and stocks used in the Materials and methods section (male vs. female, het versus hemi, what lines are used, etc.). The current version is a little scant.

Structures and analyses

Table 1 and Table 2 should include statistics from the Ramachandran plot or a Molprobity score, and estimated error estimates of the structures.

Subsection "Shared and divergent features in the structures of Dpr--DIP heterocomplexes". \"Hence, different Dpr-DIP complexes can be established not only through shape complementarity between Dpr and DIP surfaces, but also by small but significant movements of the Dpr and DIP monomers with respect to each other, a mechanism not commonly recognized for related interaction pairs.\" Are there really small but significant movements of the Dpr and DIP monomers with respect to each other? To conclude this the authors must more accurately describe the differences between the structures.

Are the DIP Ig1s subunits truly displaced versus the DPR Ig1s or are the protein domain folds slightly different? If one superimposes the DIP Ig1 domains, is the fit of the DIPs very good and do the Ds then seem offset?

Please include how many Cα atoms were used in the structure for each superposition. Superpositions can vary depending on the number of Cα positions you use (or other atoms) and which these are.

Are there multiple copies of the complexes in the asymmetric unit of the different crystal forms? If so, how well do these superimpose?

Subsection "Molecular details of Dpr--DIP complex interfaces driving specificity". \"Yet, we also observed differences at these conserved positions at the structural level via rotameric changes and by rigid-body movements of DIPs with respect to Dprs (Figure 3C),..\". Please show electron density in Figure 3C to support this statement about rotameric changes.

Results section. It is quite difficult to follow the structure-based engineering strategy. Please add a (supplementary) figure that shows the interface (red highlighted residues of interface in Figure 3B) mapped onto the ribbon diagram of a prototype Dpr:DIP structure using the view shown in Figure 3A. Please then indicate the side chains of all the residues that were mutated, e.g., residues H94 and Q126 as well as all the residues mentioned in Figure 4A-F. Please also indicate for example Dpr11 A165Y F167Y K207V, Dpr10Y103A and DIP-α I83A so that the reader can easily orientate themselves and see how all these residues localize with respect to the interface (i.e., the red highlighted residues in Figure 3B) by looking at a single figure. This is important because for instance in Figure 3D it is very hard to see His94 (Dpr1) to Glu126 (DIP-ε) and where it is located with respect to the interface.

Subsection "Energetics of the Dpr-DIP complex interface". \"the hydrophobic conserved core of the interface provides much of the energy of binding, and the periphery is likely responsible for specificity.\". To evaluate this statement, the reader needs a figure as requested in the previous point.

Other points

Figure 5E is surprising. Please show the calibration markers for the SEC column. Please indicate where the dimer and the monomer are expected. What are the concentrations shown (please add to legend). Please explain why the magenta and mustard concentrations run so differently? Are these both monomers?

It is not clear in Figure 5 ---figure supplement 1 Figure how the curves in Figure 5E could be used to calculate the ratio of monomer to dimer, leading to an estimated KD of 10-40 µM. This is a key point used to argue that DIP homodimers form with somewhat less affinity than Dpr:DIP heteromers.

The legend of Figure 5 ---figure supplement 1 Figure states: \"Dimer fraction was calculated by identifying monomeric and dimeric elution velocities and calculating monomer and dimer fractions for any given peak position.\" However, the trailing shoulders of the peaks in Figure 5E cannot be assumed to be dimer or monomer based on the elution position in the chromatogram alone because of protein loading issues. Large amounts of protein will have larger trailing peaks. So, the contents of the peaks must be validated by PAGE (native gels) to demonstrate dimer, monomer or a mixture.

Likewise, Figure 6D is surprising as well. If you have a monomer-dimer equilibrium you would expect two resolved peaks (e.g., the red curve for the dimer and the blue curve for the monomer). But a mixture should show two peaks/adjacent bumps (one for the dimer and one for the monomer) not something in the middle (green curve).

Is there perhaps a typo for the green curve in Figure 6D which reads 59 μM? Please show the calibration markers for the SEC column in Figure 6D.

For all SPR data please add the model used (presumably 1:1 interaction model) to each curve so the reader can see how well the data fits the model and thus how accurate the KD are that are calculated based on the data. Please state in the legend which interaction model was used.

10.7554/eLife.41028.040

Author response

> Summary:
>
> This manuscript presents a structural study of proteins from the immunoglobulin superfamily, Dprs and DIPs, which have been reported to regulate synaptic connectivity in the Drosophila central and peripheral nervous systems. The authors use evolutionary, biophysical and biochemical approaches to analyze sequence similarities and differences in specific regions of Dpr/DIP heterophilic complex, including the hydrophobic core, in order to evaluate binding specificity after mutating amino acids at the interface. The authors also compare the structure of a homodimer of DIP with heterodimers between DIP and Dpr. They generate multiple variants that selectively abolish homodimerization of DIP-α, or the formation of heteromeric complexes of DIP-α with Dpr10. Using the Drosophila larval neuromuscular junction as a model, the authors conduct in vivo studies to further test the roles of DIP-α/Dpr10 complexes and DIP-α homodimers in neuromuscular circuit wiring. The authors highlight the function of cis-dimers of DIPs in regulating synaptic wiring, on top of the reported heterodimeric trans interactions between DIPs and Dprs.
>
> The structural studies are extensive and outstanding and will provide useful information for the research community focusing on proteins containing immunoglobulin domains. While the quality of the structures data and analyses is generally high, the in vivo study of DIP-α/Dpr10 should be improved to better support the conclusions as outlined below.
>
> Essential revisions:
>
> Overall
>
> It would greatly strengthen the work to more clearly highlight what the novel aspects are. What do we now know that we did not know before about how the D:DIP system works? Several strategic sentences placed throughout the text would be very helpful for the reader.

We thank the reviewers for these comments. We feel we have addressed their concerns to the best of our ability.

> In vivo experiments
>
> Some alternative explanations for the Dpr10 / DIP-α mutants need to be considered: what evidence exists that the only defect in Y103A is its interaction with DIP-α? The data suggest the authors\' preferred model IF there are no other defects in the function / ability to interact with other downstream molecules of this particular Dpr10 mutant. Is this true? If this evidence does not exist, the authors should at least highlight that possibility more clearly.

Dpr10 was first reported in the literature as part of our large-scale protein interactome dataset, which identified DIP-α and cDIP as the only binding partners (Özkan et al., 2013). To address the possibility that Dpr10 Y103A mutation might break an interaction with cDIP, we repeated the binding assay with cDIP. Our results (the new Figure 6---figure supplement 2B) now show that Y103A does not affect cDIP binding. However, we agree with the reviewers that we cannot rule out downstream effects of this single-site mutation mediated by unknown binding partners. The text reflects this now.

> A similar argument for DIP-α I83A- the mutation removes some of the interaction ability with Dpr10. How can the authors ensure that this removal doesn\'t also affect the system? What if the phenotype is sensitive to Dpr10 interaction levels? Though these may be the most parsimonious explanations, they have not been conclusively shown by the data and more information should be offered or an appropriate scaling back of the conclusions and recognition of alternate explanations should be made.

We agree with the reviewers. The known heterophilic binding partners of DIP-α are Dpr6 and Dpr10 -- cDIP does not bind DIP-α (Özkan et al., 2013). We already show in Figure 4---figure supplement 3 that the DIP-α I83A mutation does decrease affinity towards the closely related Dpr6 binding by \~700 fold, and we expect a similar effect for Dpr10--DIP-α Ι83Α binding. The expected partial loss of affinity in the Dpr10--DIP-α I83A interaction due to the I83A mutation might illicit a (partial) phenotype.

For our revision, we conducted a titration series of DIP-α wild-type and the I83A mutant against Dpr10 using ECIA. In the context of our high-avidity binding assay designed to mimic adhesion molecule interactions between molecular clusters on two-dimensional surfaces, the DIP-α I83A mutant binds Dpr10 not weaker, but \~8x stronger than DIP-α WT. This apparent higher heterophilic affinity for I83A is likely due to abolishment of the competing DIP-α--DIP-α interaction, which is only present for DIP-α WT in the context of the highly clustered ECIA. Even though we expect DIP-α I83A to bind Dpr10 weaker, lack of competing DIP-α homodimerization allows for DIP-α I83A to retain effective binding to Dpr10 better than the WT. Unfortunately, it is very hard to predict what would happen on a neuron, and whether the SPR setup (Figure 4) or the ECIA (Figure 6---figure supplement 2) is more representative of the physiological interaction. Any DIP mutant that only removes homodimerization may effectively increase Dpr affinity depending on the avidity (clustering and local concentration) of the binding partners in the system being studied.

Based on these results, DIP-α I83A may be a valuable tool to test the functional outcomes for lack of homophilic DIP-α binding, while the heterodimer (DIP-α--Dpr10) can still form. However, we believe the safer course would be to explicitly state alternate explanations in our manuscript, as the reviewers suggest. We have changed the results and Discussion sections to reflect this.

> The NMJ studies lack certain controls and experiment information -- especially in Figure 7 and Figure 8, the data lack a wild-type control, a base loss-of-function to evaluate the phenotype, and sample sizes for all experiments. For instance, a Gal4 control or the control with UAS single transgene background should be added. What is Is innervation of muscle 4 normally? Does the heterozygous condition cause a partial phenotype? Or is that normal? Further, the authors cite that Dlg staining is used to tell the difference between Ib and Is boutons, but Figure 8A has no Dlg staining. This should be included. Though Ashley et al., is cited, it is not vetted by peer review. Therefore, additional data are needed here to assess the phenotype.

These controls have now been added to the manuscript. See Figure 7G and Figure 8C for updated figures with heterozygous UAS transgene controls. These controls all demonstrate the \~80% innervation frequency of muscle 4. The heterozygous DIP-α-GAL4 condition is not statistically different from wild type (p\>0.5). Anti-Dlg labeling has been added to Figure 7 (formerly Figure 8).

> The interpretation of the results in Figure 7 is confusing. The evidence about the requirement of DIP-α\'s for proper targeting of MNISN-1s boutons appears later in Figure 8A,B. This reverse order makes the interpretation hard to follow in Figure 7. The authors should re-arrange the figures.

The figures have now been rearranged and we feel this greatly improves the flow of the manuscript. We thank the reviewer for this keen observation.

> The authors do not show the effects of gain-of-function of Dpr10 or its variants in the muscle in a DIP-α hemizygous mutant background. This is the direct evidence to suggest that DIP-α is required for the loss of MNISN-1s boutons when overexpressing Dpr10. More appropriately, the authors should mutate endogenous Dpr10 to a form that does not bind to DIP-α, and test if MNISN-1s boutons are lost. The negative results after gain-of-function of a Dpr10 variant only suggest that an excessive amount of this Dpr10 variant is insufficient to affect 1s bouton targeting.

The reviewer is correct; we did not show this genetic interaction. We have now included this data in Figure 8C and feel it has improved our stance that this is a Dpr10-DIP-α specific gain of function phenotype. Although we agree that mutation of endogenous Dpr10 would be ideal, there was not adequate time to perform this experiment.

> In Figure 7, a single muscle driver Mef2-Gal4 was used to overexpress the Dpr10-V5 and its variant, and the quantification in Figure 7C suggests that it leads to an increase of 1s bouton innervating m4. Using independent lines with stronger or weaker expression than Mef2-Gal may result in different outcomes and hence, might provide more information about the effects of overexpression of Dpr10 variants.

We apologize for any confusion on our part. We now show that Mef2\>dpr10 induces a gain-of-function phenotype that reduces the frequency of m4 innervation from 80% to 25% (Figure 8C). This phenotype is replicated with another strong muscle GAL4 line, 24B-GAL4, but not with a weak muscle GAL4 line, BG487-GAL4 (Figure 8---figure supplement 1).

> Could 1s bouton sizes and numbers be quantified to compare with wild type in Figure 7 and Figure 8? These may provide additional information about the functional influence of DIP/Dpr interactions.

We thank the reviewers for making this suggestion, however, this data does not relate to synaptic connectivity and instead relates to synaptic outgrowth, which is beyond the scope of this manuscript.

> A concern in Figure 8E and 8F is that UAS-DIP-α I83A may not function at all in vivo, as only negative results are reported in the paper using this transgene. Testing the effect on 1s boutons after overexpressing DIP-α I83A in a wild type background would be a way to evaluate the functional role of this variant. The expression level of DIP-α after overexpression of DIP-α I83A could also be tested for a comparison with the wild type.

The reviewer makes a good point about the DIP-α^I83A^ function, as we only show expression in a mutant background. Without including the controls, the phenotypes were unclear. Now with the appropriate controls, as suggested by the reviewer, we can show that either UAS-*DIP-α* or UAS-*DIP-α^I83A^* expression in a heterozygous mutant background (Figure 7G) or in a wild type background (Figure 7---figure supplement 1F) show no change in innervation of m4. We also compare expression levels of the two transgenes and find no significant change between them (Figure 7---figure supplement 1A). These additional experiments suggest that both constructs are expressed and trafficked normally, and that expression of UAS-*DIP-α^I83A^* does not alter innervation.

> Figure 7 and Figure 8. It would be helpful to indicate in the legends how many m4s were analyzed and quantified (Figure 7C and Figure 8G).

We apologize for this oversight on our part. We have now included four tables to accompany each figure with the mean, SD and SEM for each graph, as well as number of animals and number of hemisegments quantified.

> Overall, the NMJ section is written such that particular aficionados will understand it, but few others will. The authors should present a more general assessment, offering more to discuss the difference between type Ib and Is boutons (this knowledge is mostly taken for granted in the current version), and describe the DIP / Dpr reagents used (key amongst being the knowledge of what DIP-α-GAL4 is and that it is also an allele -- this was unclear unless you have intimate familiarity with exactly what reagents the authors are employing). This will aid in accessibility, understanding, and proper assessment by the field of the story.

Again, we apologize for the oversight. We have now gone back and carefully explained phenotypes, controls and methods in a thorough manner.

> Presumably if they\'re looking at heterozygous versus hemizygous, this gene is on X, so the two larvae being compared are male and female. Is this appropriate? Are there any inherent sex differences in any of these terminals that could confound this interpretation?

As stated above, the lack of clarity on our part was an oversight. We have now improved our description of this genotype as well as included male and female controls to show there is no sex specific differences in m4 innervation (Figure 7---figure supplement 1B).

> Please include more detail in Drosophila genetics and stocks used in the Materials and methods section (male vs. female, het versus hemi, what lines are used, etc.). The current version is a little scant.

We did not include a final version of our Materials and methods section in our initial submission and neglected to include this with the version that went out to reviewers. We have now included a complete Materials and methods section in this version of the manuscript.

> Structures and analyses
>
> Table 1 and Table 2 should include statistics from the Ramachandran plot or a Molprobity score, and estimated error estimates of the structures.

We had used a template from a prominent Structural Biology journal for our crystallographic tables. As the reviewers noticed, the tables lacked important validation criteria. This has been corrected in both tables. We thank the reviewers for pointing this out.

> Subsection "Shared and divergent features in the structures of Dpr--DIP heterocomplexes". \"Hence, different Dpr-DIP complexes can be established not only through shape complementarity between Dpr and DIP surfaces, but also by small but significant movements of the Dpr and DIP monomers with respect to each other, a mechanism not commonly recognized for related interaction pairs.\" Are there really small but significant movements of the Dpr and DIP monomers with respect to each other? To conclude this the authors must more accurately describe the differences between the structures.

The original manuscript mentioned: "When the Dpr subunits are forced to align, the three DIP subunits are slightly misplaced, with DIP-γ (dark gray in Figure 2 and Figure 3) more distant from the other DIPs (\~1.2 Å at the interface and up to 3 Å at the back face of the IG domain, Figure 3A)". However, the most remarkable point here is that *CC'C"FG* sheets are separated from each other at different distances when the three Dpr-DIP complexes are compared. The new Figure 3---figure supplement 1B top image shows this clearly. We thank the reviewers for highlighting the need to better demonstrate this point.

> Are the DIP Ig1s subunits truly displaced versus the DPR Ig1s or are the protein domain folds slightly different? If one superimposes the DIP Ig1 domains, is the fit of the DIPs very good and do the DPRs then seem offset?

The domain folds among the Dprs and the DIPs show strong matches between the different complexes. For example, the Cα atoms have rmsd values ranging from 0.59 to 0.79 Å among all DIP IG1 domains (for all Cα atoms, no outliers are rejected). This is not surprising, since the all DIPs are all very similar in sequence: DIP-α, -γ and -η do not even contain a single insertion/deletion in the multiple sequence alignment of IG1s. The complexes have much higher RMSDs with respect to each other: especially Dpr11-DIP-γ complex is 1.7-2.0 Å different from the others.

Aligning of DIP interface amino acids causes similarly high displacement between Dpr chains.
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> Please include how many Cα atoms were used in the structure for each superposition. Superpositions can vary depending on the number of Cα positions you use (or other atoms) and which these are.

We thank the reviewers for pointing this out. When calculating RMSDs, we use only Cα atoms, and turn off outlier rejection cycles. No outlier rejection means that all single subunit comparisons are for 100 or 101 Cα atoms, except for Dpr11 (94 resolved amino acids in crystal structure).

> Are there multiple copies of the complexes in the asymmetric unit of the different crystal forms? If so, how well do these superimpose?

Of the complex structures we report, Dpr1-DIP-η complex has two complexes in the asymmetric unit (asu). The RMSD between the complexes is 0.27 Å over 203 Cα atoms. The Dpr10-DIP-α crystals also have two complexes per asu, and their RMSD is 0.36 Å over 204 Cα atoms. These low RMSD values, similar to ML coordinate error estimates, show very close matches between the NCS-related copies.

> Subsection "Molecular details of Dpr--DIP complex interfaces driving specificity". \"Yet, we also observed differences at these conserved positions at the structural level via rotameric changes and by rigid-body movements of DIPs with respect to Dprs (Figure 3C),..\". Please show electron density in Figure 3C to support this statement about rotameric changes.

We have added panels to Figure 3---figure supplement 1C,D in the revised manuscript to demonstrate electron density quality at these side chain positions.

> Results section. It is quite difficult to follow the structure-based engineering strategy. Please add a (supplementary) figure that shows the interface (red highlighted residues of interface in Figure 3B) mapped onto the ribbon diagram of a prototype Dpr:DIP structure using the view shown in Figure 3A. Please then indicate the side chains of all the residues that were mutated, e.g., residues H94 and Q126 as well as all the residues mentioned in Figure 4A-F. Please also indicate for example Dpr11 A165Y F167Y K207V, Dpr10Y103A and DIP-α I83A so that the reader can easily orientate themselves and see how all these residues localize with respect to the interface (i.e., the red highlighted residues in Figure 3B) by looking at a single figure. This is important because for instance in Figure 3D it is very hard to see His94 (Dpr1) to Glu126 (DIP-ε) and where it is located with respect to the interface.

We share the frustration of the reviewers. The interface is a curving three-dimensional space, and a single two-dimensional image fails to show all residues of importance. Following the reviewer's advice, we have added Figure 3---figure supplement 1 and Figure 4---figure supplement 4 to aid visualization of the amino acids at the interface.

> Subsection "Energetics of the Dpr-DIP complex interface". \"the hydrophobic conserved core of the interface provides much of the energy of binding, and the periphery is likely responsible for specificity.\". To evaluate this statement, the reader needs a figure as requested in the previous point.

We have improved added a figure to make this point clearer. Please see Figure 3---figure supplement 1A.

> Other points
>
> Figure 5E is surprising. Please show the calibration markers for the SEC column. Please indicate where the dimer and the monomer are expected. What are the concentrations shown (please add to legend).

The calibration markers for the SEC column were on Figure 5E as filled triangles above the curves (labeled as 17 and 44 kDa). DIP-η IG1 runs \~30% smaller than its expected elution volume for a globular protein of same molecular weight, both for the monomer and dimer, likely due to transient non-specific interactions with gel filtration resin. While this kind of behavior is common, it does not affect our analysis of dimerization. Finally, we have added labels for protein concentrations. We calculate protein amounts in each peak not by the amounts loaded, but using the areas under each peak, to correct for any protein loss common to chromatography injections and runs.

> Please explain why the magenta and mustard concentrations run so differently? Are these both monomers?

This comment, and others below, indicated to us that we missed an opportunity to explain in detail a feature of low-affinity, fast-kinetics complexes in our manuscript. When a protein is in a fast equilibrium of monomers and dimers (such as DIPs), one cannot observe separate monomer and dimer peaks in gel filtration, but a peak at one intermediate position determined by the ratio of monomers-to-dimers. This is conceptually identical to how NMR chemical shifts separate into peaks when a protein experiences slow-exchange kinetics but take single intermediate positions in fast-exchange kinetics. To our knowledge, this behavior was first rigorously demonstrated and simulated thirty years ago by Stevens, (1989). Further details of this behavior can be found in a protocol paper by his group (Wilton et al., 2004).

This phenomenon might be best simplified if one imagines a group of molecules traveling within a gel filtration column. Since the rates of P+P→P~2~ and P~2~→P+P conversions are fast and happening several times per second for a fast-kinetics dimer, any given P molecule can recycle through monomer and dimer many times within one gel filtration experiment: up to 1,800 times if *k*~ex~ = 1 s^-1^ and the elution time = 30 min. So, the average migration speed of the protein molecule will be more than the dimer's but less than the monomer's. The fast exchange rate will not allow monomeric and dimeric proteins to separate into peaks. In the case of slow kinetics (e.g., *k*~ex~ \> 1 h^-1^), a protein is unlikely to convert between monomer to dimer during one chromatography run, and the two populations will separate into two peaks.

Stevens lab's simulations describe how such chromatograms should appear in their 2004 paper. Panel A below shows actual data for a fast-exchange monomer/dimer with a *K*~D~ of 10 µM, and panel B shows expected chromatograms based on simulations. Our gel filtration results in Figure 5 and Figure 6 closely match their experimental and theoretical data.

We also would like to note that low-affinity/µM interactions almost always have fast kinetics, even though this is not theoretically required. In our case, our SPR results here and in Carrillo et al., (2015) show the fast kinetics.

In short, the mustard peak in Figure 5E belongs to protein molecules at a low concentration, which have spent most of their time on the SEC column in a fast-eluting monomeric state, and less time as a slow-eluting dimer. The magenta peak belongs to a sample 5x more concentrated, which has existed approximately same amount of time as a fast-eluting monomer and as a slow-eluting dimer. The peaks further to the left, at even higher concentrations, mostly existed as a dimer during the 1-hour long SEC experiment.

> It is not clear in Figure 5 ---figure supplement 1 how the curves in Figure 5E could be used to calculate the ratio of monomer to dimer, leading to an estimated KD of 10-40 µM. This is a key point used to argue that DIP homodimers form with somewhat less affinity than Dpr:DIP heteromers.

We have now corrected this oversight and expanded the methodology further in the manuscript. However, we would still like to emphasize that the evidence for heterodimers having higher affinity is not limited to these calculations.

Finally, we show in the manuscript that the Dpr-DIP heterodimer affinities may be underestimated (i.e. appear weaker) in SPR experiments due to competing homodimers. Therefore, it is more likely that we are underestimating heterophilic affinities, and the heterodimers are even more stronger than homodimers.

> The legend of Figure 5 ---figure supplement 1 states: \"Dimer fraction was calculated by identifying monomeric and dimeric elution velocities and calculating monomer and dimer fractions for any given peak position.\" However, the trailing shoulders of the peaks in Figure 5E cannot be assumed to be dimer or monomer based on the elution position in the chromatogram alone because of protein loading issues. Large amounts of protein will have larger trailing peaks. So, the contents of the peaks must be validated by PAGE (native gels) to demonstrate dimer, monomer or a mixture.

We agree that when peaks trail it is problematic to assign an average elution volume, or migration speed, to the protein sample in the experiment. These "trailing shoulders" are expected (especially at intermediate concentrations), because the peak's leading edge will start to separate from the peak and will migrate faster as the protein is more diluted and will lean further towards the monomeric state. This issue stem from the fact that in gel filtration chromatography the entire protein sample is not in equilibrium across the elution profile. Partly because of this, we report dissociation constants as a range, rather than precise numbers. Also, using an absorbance-weighted average value as the elution volume does not significantly change the apparent *K*~D~ values calculated from the binding isotherm.

The "trailing shoulders" is also a feature reported in Stevens' simulations, explicitly mentioned in Wilton, Myatt and Stevens, (2004) further supporting our results.

Finally, the native PAGE experiment suggested by the reviewer will also not give multiple bands, but only an intermediate and probably fuzzy band, simply because the separation of PAGE bands happens on the timescale of minutes, while DIPs interconvert between monomer to dimer in the millisecond to second timescale.

> Likewise, Figure 6D is surprising as well. If you have a monomer-dimer equilibrium you would expect two resolved peaks (e.g., the red curve for the dimer and the blue curve for the monomer). But a mixture should show two peaks/adjacent bumps (one for the dimer and one for the monomer) not something in the middle (green curve).

As explained above, in a fast-exchange monomer-dimer equilibrium, one should only observe one intermediate peak, and no separate peaks. Only in the slow-exchange regime, or when a kinetic trap can prevent quick conversion between monomer to dimer, multiple peaks can be observed. We have indeed worked with such proteins and published such data before (the cell-cycle control protein Mad2 can exist in multiple states, which are stable for hours to days, and monomers or dimers can be separated (Hara et al., 2015)). For such behavior, the kinetics of oligomerization and dissociation should be happening in timescales of at least minutes to hours.

> Is there perhaps a typo for the green curve in Figure 6D which reads 59 μM? Please show the calibration markers for the SEC column in Figure 6D.

There is no typo. We need to test DIP-α and DIP-η homodimerization at \[DIP\] concentrations in the high μM and even millimolar range, as a result of their weak affinities compared to the heterodimers. Figure 6D shows gel filtration results at 7.8 µM, 59 µM and 1.13 millimolar concentrations. It appears that only at 1.1 mM, DIP-α is in ≥90% dimer. Such weak affinities (and even worse) are observed for well-established cell adhesion complexes; classical Cadherins homodimerize with *K*~D~s in the range of 14 µM to 127 µM (Vendome et al., 2014), which are still strong enough to create adherens junctions.

The calibration markers are shown in Figure 6D as triangles above the curves. Unlike our DIP-η IG1 construct (pI = 8.7), DIP-α IG1 (pI = 6.9) elutes as monomer and dimer at volumes expected for a globular protein of the same size.

> For all SPR data please add the model used (presumably 1:1 interaction model) to each curve so the reader can see how well the data fits the model and thus how accurate the KD are that are calculated based on the data. Please state in the legend which interaction model was used.

The binding model fits to the SPR data for all Dpr-DIP complexes are in Figure 4A-D, and all raw data are in the supplemental figures. This was mentioned in the legend for Figure 4 but needed to be further stated in the main text. We have added wording to the main text and expanded the Figure 4 legend. Also, the figure supplements include tables for each *K*~D~ measurement, and the standard error of mean values associated with those fits.

SPR data was fit using the 1:1 interaction model, except in Figure 5---figure supplement 1D, which measures DIP-η homodimerization using SPR. For this dataset, we modified binding equations to account for homodimerization in solution, and we fit the data to the modified model in MATLAB, as mentioned in the original manuscript. We had failed to include the equations used for DIP-η homodimer fitting in the Methods section, which has been remedied in the revised manuscript.
